In a cancer radiation treatment, Hadron therapy plays an important role as a technique with a high accuracy providing treatment results better than conventional radiation therapy methods such as chemotherapy. The laser-based Hadron therapy techniques are attractive due to their compactness in producing miniaturized particle accelerators and supporting a more intense electric field compared to other methods. A good-quality laser beam focusing and guiding in a cold plasma channel leads to an accurate and precise laser spot after focus, which is an important necessity in medical aims and occurs in µm-wavelength (ultra-short pulse) laser types. A method used to level up this treatment approach has been emerged by using high-power lasers along with plasma channels as a source for high energy to more effectively perform the Hadron therapy. Additionally, cancer treatment by using ions as the particle transferor is preferred over other methods for Hadron therapy due to some physical properties such as maximum energy deposition to the cancerous targets providing a better dose delivery to the tumor. In this paper, multiple simulations around the dose delivery procedures were presented for efficient dosimetric evaluations. Moreover, the effects of the electric field on the particle energy enhancement were evaluated in the presence of the plasma channel. Finally, it was demonstrated that the use of Oxygen ion in the presence of plasma channel is the appropriate approach due to its minor energy dissipation through matter on the way to the tumor for a better dose delivery which was impressed with radially polarized laser accelerator simultaneously. The proposed research demonstrated that the Hadrons can reach the maximum accelerated energy and convey the maximum path through the body to the cancerous target and finally deliver the sufficient dose to the tumor by using Oxygen ion beam in a cold plasma channel, which is low in density, with appropriate laser power. Consequently, Hadron therapy by using Oxygen ionization in the laser-plasma based accelerator is an impressive and efficient method for precise cancer treatment. Lastly, Laser-Plasma accelerators have three important limitation factors of ''Energy Spread'', ''Dephasing Length'', and ''Pump Depletion'', which can limit the energy increasing. In this paper, facing up to these limitations was a critical challenge in Hadron therapy for better Hadron acceleration and dose delivery.
I. INTRODUCTION
As a particular kind of oncological radiotherapy, Hadron therapy uses the hadrons (non-elementary particles made of quarks and antiquarks) to acquire better dose deposition when contrasted and the ones of X-rays utilized in the conventional radiotherapy [1] . In order to deal with cancer, this strategy appears as a pioneered method since there are enough ballistic properties of ion beams in this treatment. This amount of ion beams advances the arrangement of one The associate editor coordinating the review of this manuscript and approving it for publication was Chong Leong Gan . of the fundamental issues of the radiation treatment, the irradiation of a malignant tumor with an adequately strong and homogeneous dose, guaranteeing that the absorbed light of the surrounding healthy tissues and organs would be minimal [2] . The approach depends on increasing the acceleration of the seen particle in accordance with the high power laser with substance which has been influenced by radially polarized laser.
Contrasted with the standard accelerators of charged particles utilized in the present day hadron treatment sections, the laser particle acceleration is progressively profitable and attributable to compactness and generally the minimal cost of laser accelerators because of possibility to build up the all-optical plan with gantries. This happens due to the plausibility to build up the all-optical plan with gantries. The right amount of particle acceleration, observed in the lab through the interaction of high-control laser radiation with different targets, makes utilizing the laser-plasma as a compact source of high-energy particles to perform Hadron therapy [2] .
For an additional description about the main aim of the paper-energy enhancement and its procedure-it should be noticed that we can better treat diseases such as cancer by using the laser in accompanying with medicine in the near future through applying high-energy ions in the particle therapy [3] . Due to better acceleration, energy enhancement can lead to better results for cancer treatment through Hadron therapy. This can only be done by using electron movement in the electric field, which will be relativistic at the intense regime. The laser-plasma interactions in this group can provide ascent to a wide scope of new applications. One of the plasma features is its ability to create a remarkable capacity for developing energetic electrons from cooperation with a high power laser. The examinations conducted in the past on the electric force related to the laser field (if the duration of the laser pulse is similar to or shorter than the plasma wave period) showed that the filed can awaken a Wakefield propagating with a speed near the speed of light. If the electrons with adequate energy coordinating the accelerating electric fields are infused into the Wakefield (a plasma wavelength), they may have been trapped and leveled up to the particles with higher energy called as the laser Wakefield acceleration. It is notable that the electric field with two parts, one in the radial direction (wavering toward or far from the center) and the other in the axial direction (oscillation along the propagating heading) and in the presence of the plasma channel represent one kind of qualities for a radially polarized laser, which associates with plasma field in contrast with the linearly polarized laser [4] .
The process of change in the spot size of the beam with both laser and plasma parameters is one of the most significant factors in understanding the behavior of laser beams during the propagation process through the plasma. Thus, laser beam focusing and laser beam guiding play a crucial role in Laser-Plasma accelerators especially in medical purposes [5] . Authors illustrated the minimum laser spot diameter in this paper based on laser wavelengths followed by demonstrating the efficient laser guiding in a dielectric capillary tube in a low-density plasma channel.
A laser with a specific sufficient intensity can be created by making a channel through exceedingly nonlinear laser-plasma interactions. The plasma channels are assumed to do a critical job in the accelerators by controlling the laser for proficient interactions. A plasma channel can be utilized as a productive mechanism to increase electron speed in a laser Wakefield acceleration. In this paper, the electron acceleration was studied by a radially polarized laser within the sight of a preformed plasma channel. The process of laser radial polarization leads to the creation of an intense force in the central area which can accelerate the electrons to a high energy level. The electric force emerging in an ion channel helps to limit the interacting between electrons and will infuse them in the accelerating field for further increased speed. In this way, both the plasma channel impact and the radial polarization of the laser fundamentally upgrade the energy of an accelerated electron [4] . Finally, the simulation was implemented based on the quanta of energy in radially polarized laser pulses to enhance the energy of electrons for a better acceleration. The major challenge of this method was the operation of the particle delivery procedure on the patient being significant for treatment. Subsequently, a pillar beam-line was required to distinguish the dissimilar particle beam with an energy range directing this beam to the patient and considers a defined dose delivery. In order to empower a patient particle delivery, the beam-line should offer an energy choice framework to pick the desired parts from the primary particle spectrum [6] . Moreover, citing the ions as proper transducers, the Bragg curve of three ions: Carbon, Neon, and Oxygen was illustrated and compared respectively and it was demonstrated that Oxygen ion is the best particle in Hadron therapy due to its minor energy dissipation through matter on its path to the tumor. The particles such as Oxygen ions have more biological advantages than light beams in radiotherapy. Oxygen ions have a higher Linear Energy Transfer (LET) and bigger Relative Biological Effectiveness (RBE) than the lighter elements. High energy ionizing radiation seems to be a suitable alternative for radiation treatment through conveying dose to the tissue and making Bragg peak in a specific zone in the objective. In addition, the dose of the Oxygen beam toward the end of the Bragg peak prompts an extensive slope keeping the retention of undesirable dosages to the sensitive and sensitive organs [1] .
In this paper, multiple procedures were investigated for better dose-delivery to the cancerous tissues in the cancer treatment process. Thereby, the effects of Radiosensitivity, Tumor morphology, and Dose-response, were studied respectively. Radiosensitivity is the injurious action of radiation in a tumor showing less radiosensitivity for less destructive tumors and more radiosensitivity for more destructive tumors per similar amount of received dose. Besides, as indicated by this paper, the tumor morphology is a determinative parameter in the dose delivery process, which precision of dosage is significant in the case of malignant tumors with complicated structures; In addition, using ions as energy transmitters appears to be a suitable approach. Furthermore, the effects of uniform and non-uniform dose delivery on the dose-response of tumors have been examined, based on which, the dose-response of tumors and organism were discussed in parallel and serial terms. Furthermore, as presented by authors, Oxygen ions are impressed with the polarized laser accelerator in the presence of plasma channel as transferor particles, enhancing the energy due to a better dose-delivery. This treatment infers the properties of ion beams to treat tumors by augmenting the dose discharged VOLUME 7, 2019 to the target and saving the healthy tissue [7] . Utilizing an extreme collimated light emission delivered by applying a high-intensity laser pulse interacting with plasma for the particle treatment of oncological disease appears to be an effective method used in these types of treatments [8] .
In this research, it was demonstrated the achievability of utilizing laser-plasma as a source of high-energy ions in the Hadron therapy process. The plasma utilized in this research, as well as some medical aims, is ''Cold Plasma'', implying that it is made in lower temperatures and has a lower plasma density; as a rule, under 1% or around one-hundred-million electrons for each cubic centimeter [9] . The target tumors and malignant growth cells with exactness and negligible dose correctly convey an ideal radiation dose delivery to the tumor and enhance the personal satisfaction amid during and after the treatment in the Hadron therapy technique. The researches demonstrated that different techniques are restricted for malignant growth treatments in the examination with Hadron therapy and this method treats a particular scope of diseases, which can cause some reactions in using it; it influences everybody in an unexpected way and may not work so well for everybody. For a better and more influential treatment, the particles with extensive initial transverse energies are needed. The accelerated particle acquires energy as an underlying energy transferor due to plasma channels. When the particle enters a human's body, it has a high speed and apportions just a little dose on its way. The absorbed dose increments gradually will be ordered with more prominent depth and lower speed; all of a sudden, they ascend to a pinnacle when the particle is at last halted, which is known as the Bragg peak [10] . In the Hadron therapy, energy-gain is the most important aim which rectifies the insufficiency of the dose delivered to the tumor. In the experimental results of this study, the maximum energy of three accelerated particles (Carbon, Neon, and Oxygen ions) were calculated and compared in the presence of plasma channel after estimating the electron energy-gain in the Laser-Plasma accelerator.
The cancer treatment with ions is preferred over other methods for Hadron therapy due to some physical properties. Ions deposit their maximum energy density in the Bragg peak at the end of their range [11] . Ions enter the patient for all intents and purposes, approximately, without any diffusion. Being charged, they can efficiently be framed as barely engaged 'pencil beams' flexible penetration depth in a way that any piece of a tumor can be precisely and quickly irradiated. In this manner, the ions permit the exceedingly conformal treatment of deep situated tumors with a millimeter exactness, giving an insignificant dose to the surrounding tissues. Another feature of light ions is having bigger natural viability concerning X-rays and protons. We summarized the physical and radiobiological contentions of this matter as follows. In a cell, an ion leaves the energy around 24 times more than a proton with a similar range. This delivers a thick segment of ionization, particularly close to the Bragg peak area of the track causing many 'Double Strand Breaks' and 'Different Damaged Sites' when crossing the DNA contained in the cell core. Along these lines, the impacts on the cell are subjectively unique in relation to the ones delivered by inadequately ionizing radiations; for example, X-rays and the protons. Indeed, these radiations cooperate essentially in a roundabout way with the DNA through the generation of dynamic radicals that, achieving the DNA, are created for the most repairable 'Single Strand Breaks' part. Therefore, high ionizing particles demonstrate their energy against hypoxic and other shrewd radio-resistant tumors such as tumors requiring the stored dosages of 2-3 times higher on the off chance to be controlled with either photons or the protons [12] .
The light ions have a Radio Biological Effectiveness (RBE) at the Bragg peak or many end-points and conveyed doses to provide much wider impacts being around multiple times bigger than the one for X-rays and protons. In the backing off an ion in the tissue, this impact winds up critical when the Linear Energy Transfer (LET), the 'Stopping Power' in physicist speech, ends up bigger than ≈20 keV /µm. Since the protons carry on this moderately high 'limit' along their full range -with the prohibition of the last tenth of a millimeter -for all intents and purposes as the electrons, which are placed in movement by the high-energy photons created by restorative linacs (linear accelerators) and have a LET in the range 0.2 − 0.5 keV /µm. Consequently, the broad radiobiological and clinical involvement with photon radiation treatment can be connected to the proton treatment [12] .
The presence or absence of Oxygen inside the cells has a strong impact on the natural effects of radiation and hypoxic tissues being known to be less radiosensitive. Such an impact-which is communicated as far as Oxygen Enhancement Ratio (OER) -particularly relies on the LET. For low LET radiation, for example, X-rays or protons, hypoxia speaks to a genuine constraint factor to the viability of the treatment. For high LET, this impact is restricted and carbon particles speak to an integral asset for the treatment of hypoxic radio-resistant tumors [13] . Finally, based on the discussed statements in this research, the authors only investigated ions-based Hadron therapy. Laser-Plasma accelerators have three major and significant limiting factors of ''Energy Spread'', ''Dephasing Length'', and ''Pump Depletion'', which are the energy-gain barriers. The energy spread is considering the phase dependence of the Wakefield along the limited-length bunch connected with the dephasing during acceleration, which highly depends on three fundamental parameters; bunch length, beam loading, proportional to the plasma density, and the injection phase [14] . In particular, a probable way to minimize the energy spread is presented, which is generated during the acceleration process through appropriate values of the mentioned parameters in a low-density plasma channel.
The dephasing length is defined as the length (longest) distance an electron can travel before it slips by half a period of the plasma wake. As the plasma wake phase velocity almost equals the laser pulse velocity, this may lead to dephasing between the plasma wake and the accelerated electrons, limiting the acceleration distance as a result [15] . Maximizing the dephasing length leads to better energy-gain in the laser-plasma accelerators, which can be achieved in a low-density plasma according to the paper. The laser pulse excites a wake as it propagates. The wake excitation leads to the laser pulse energy loss. The pump depletion length (over which the pump loses a significant fraction of its energy) can be estimated by equating the laser pulse energy to the energy remained in the wake. Once the pump depletion occurs, it is essential to stage with a fresh pump pulse [16] . We demonstrate that postponing the pump depletion i.e., to maximize the depletion length, results in energy-gain, which attained in a low-density plasma environment. Authors conducted an in-depth study on the three above-mentioned limiting factors limitation and provided a convenient method to overcome these restrictions.
This paper is organized as follows. Section II explains the Theory of Acceleration. Section III presents the Hadron Therapy Procedure Based on Laser-Plasma Accelerators. In Section IV, Experimental Results and Simulations are expounded. Section V explain the Control of Limiting on Factors on Laser-Plasma Acceleration. Section VI provides Discussion about this work. Finally, Section VII is devoted to Conclusion and Prospective Works.
II. THEORY OF ACCELERATION A. ION ACCELERATION CONCEPT
Accelerating ions with laser beams would bring out some features which are attractive for many applications. Under the effect of laser field, ions can gain energies of many MeV at the distance of a few microns and carry a charge of the order of a few µC with very low emittance. It can be realized in a strongly over dense and relatively thick target at the normal incidence of an intense laser pulse. The laser pulse ponderomotive force pushes electrons ahead, produces a cavitation zone and stuffs the electrons in front of it. An electron spike growing in front of the laser pulse reflects it and creates an electric field behind it which can accelerate the ions.
In the case of linear laser polarization, the electrons are strongly heated, which is undesirable. On the contrary, electron heating is strongly suppressed in the case of radial laser polarization. By applying a high-intensity laser pulse near its turning point, a double-layer structure is formed that propagates forward and pushes the perimeter in front of it [13] . Effective ionization during the interaction of an ultra-short and ultra-intense laser pulse with matter is one of the most important procedures for accelerating particles, which needs to gain ionization energy by accelerating through a laser beam. Ionization energy is the quantity of energy that an isolated and gaseous atom in the ground electronic state should absorb to discharge an electron. In addition, ionization is one of the principal methods by which radiation, such as charged particles, transfers its energy to the matter [17] . The laser intensity, I , in terms of the electric field, is defined as follows [18] :
where c represents the speed of light in vacuum, 0 represents the vacuum permittivity, and n represents the refractive index. Additionally, as shown as follows [19] :
where a indicates the acceleration rate, q indicates the charge, m indicates mass, K indicates the electric field, and F indicates the force. In accordance to Eq. 1 and Eq. 2, the intensity of the laser is just as to the second power of the electric field; then, when the electric field increases, the ion also speeds up and the result would be a better rate in the acceleration of ion.
B. TYPES OF PREVALENT HADRON ACCELERATORS 1) FFAG ACCELERATORS
The Fixed Field Alternating Gradient (FFAG) accelerator combines the concept of the synchrocyclotron, in which the magnetic field is fixed and the Radio Frequency (RF) varies with the use of separated sector magnets. The sector magnets are designed to include strong, alternating gradients, providing the beam focusing. FFAGs have a typical diameter of about 15 m with a weight up to 200 tons. The sector magnets are not easy to build and the RF structures need to be compact and should have a high-voltage gain. FFAGs are still attractive with regard to cyclotrons and synchrotrons as we can actively vary the energy at a high repetition rate by simply switching off the RF when the required energy is achieved. Such accelerators are weak in energy width and have short pulse duration and not enough peak dose rate [20] .
2) LINEAR ACCELERATORS
A linear accelerator (linac) is a device using high Radio Frequency (RF) waves aimed at accelerating the charged particles to high energies in a linear path inside a tube-like structure called the accelerator waveguide. Such accelerators are weak in terms of energy width and have short pulse duration, while they lack a sufficient peak dose rate. In addition, linacs accelerators have complex hardware and structure [21] .
3) CYCLOTRON
A cyclotron, a linear accelerator (linac), uses different accelerations by a Radio Frequency (RF) electrical field and has a complex structure. Nonetheless, the ions in a cyclotron are limited to move in a spiral path by a magnetic field. The ions are injected between two semicircular electrodes called ''Dees'' in the center of the magnet. As the particle spirals towards the outside, every time it gets accelerated crossing the gap between the Dees. The time a particle takes to finish an orbit is fixed as the distance traveled rises at a rate equal to its velocity, which allows it to stay in phase with the Radio Frequency. This condition changes as the relativistic energies are approached, which limits the cyclotrons in energy. They are weak in energy width, pulse duration, and peak dose rate. However, Cyclotrons are still used all over the world for medical purposes [21] .
4) SYNCHROTRON
In a synchrotron, a magnetic field keeps the orbit radius constant, which increases with moment as a particle's momentum rises. The synchrotron has been created to overcome the energy limitations of cyclotrons imposed by special relativity, but the energy width remains unsatisfactory [21] .
5) SYNCHROCYCLOTRON
This is a unique cyclotron form in which the frequency of the electrical field of the driving radio frequency differs to compensate for the relativistic effects as the velocity of the particles approaches the speed of light. This goes against the conventional cyclotron, where the frequency is fixed. Unfortunately, the innovation enabled the synchrocyclotron to bypass the classical cyclotron's energy limit at the same time resulted in lower and lower duty cycle beams being the reverse of what's needed for accurate tests [22] .
6) DIELECTRIC WALL ACCELERATORS
These are compact accelerators for tumor treatment. In a tube made of a stack of High Gradient Insulator (HGI) disks that alternate with conductive components, the protons are accelerated. High-voltage switching devices are linked by a laser pulse to each conducting sheet. The issues of this accelerator include the focusing of the accelerated protons, the rate of repetition of the pulsed laser, and the short pulses which cause severe limitations for the ion source being intended to provide an enormous number of protons per pulse [20] .
7) LASER-PLASMA ACCELERATORS
This type of accelerator will be fully and comprehensively explained in the next sub-section, due to its significance. Although, there are several different types of accelerators such as Cockroft-Walton Accelerators, Van de Graaff Accelerators, Betatrons, and Microtrons, here, the most common used Hadron accelerators can be described here in recent years. In addition, Table 1 shows the comparison of typical beam parameters of Laser-Plasma accelerators and different conventional accelerators as examples of the traditional clinical particle accelerations. As can be inferred from the aforementioned and the features extracted from Table 1 , the energy width of Laser-Plasma accelerator is clearly wider than linac, dielectric wall accelerator, and the cyclotron. Moreover, the pulse duration of Laser-Plasma accelerator is more compressed than others. The peak dose rate is another significant feature being specifically higher in Laser-Plasma accelerator in comparison with linac, dielectric wall accelerator, and cyclotron. The Laser-Plasma accelerators are then amazingly strong and adequate in energy width, pulse duration, and peak dose rate compared to other accelerators, and in the meantime, which can provide a better dose delivery and high efficiency acceleration in the Hadron therapy for an effective cancer treatment. Moreover, much higher field strengths can be obtained with Laser-Plasma particle accelerators compared to other accelerators [23] .
As mentioned regarding the Hadron accelerators, Laser-Plasma accelerators are much smaller and less complex than the conventional ones such as FFAGs, linacs, or cyclotrons accelerators. Thus, the Laser-Plasma accelerators in Hadron therapy have a high potential since the bench top accelerator systems can obviously reduce the cost of a particle therapy facility. Hence, one can say the Laser-Plasma acceleration benefit Hadron therapy compared to other Hadron acceleration concepts and, accordingly, this accelerator was selected for this study.
C. LASER-PLASMA ACCELERATORS
If one can make the electric field, and in the meantime, do not warm the electrons excessively, as characterized in cold plasma, the speed of an ion could be better controlled; thus, they can neutralize the ion pack as the increasing speed process ends, which is the main purpose of the laser radiation accelerating plan [13] . At low weights, when an electric current is gone through them, the ionization happens by a crash in gases. They drive different electrons out of the neutral and noble gas molecules if the electrons establishing the current have adequate energy. At such conditions, delivering ion matches that exclusively comprise of the resultant desirable ion and the disengaged negative electron. Negative ions are likewise framed as a bunch of the electrons which connect themselves to the n gas atoms. Gases may likewise be ionized by intermolecular crashes at high temperatures [9] . At last, ionization can make the likelihood of increasing speed. Fig. 1 shows a straightforward scheme of a laser-plasma driven ion accelerator in Hadron therapy. The accelerator comprises of a short-pulse high-intensity laser and an objective, for example, a thin foil, put in a vacuum chamber [24] . The laser beam cooperating with the objective produces plasma where the electrons are somewhat isolated from ions by the activity of the laser field. An exceptionally strong electric field is delivered between the layer of electrons and the particles. This field pulls the particles, which pursue the moving electron layer. The field quality can achieve amazingly high qualities (up to tens or even hundreds of GeV /cm) [25] . By using particles responsible for accelerating the laser-plasma, a longitudinal accelerating electric field is produced with the ponderomotive force of an ultra-short and ultra-intense laser. Corresponding to the slope of the laser force, this force drives the plasma electrons out of the laser beam way, isolating them from the ions which makes a traveling longitudinal electric field in the wake of the laser beam with a stage speed near the speed of light, which is the most appropriate situation to accelerate the ions to relativistic energies.
Such an electric field can achieve amplitudes of a few hundred Giga-volts per meter. Furthermore, the characteristic scale length of the Wakefield is the plasma wavelength, 1030 µm for electron densities n e = 10 18 −10 19 cm −3 . Thus, on the off chance that we can figure out how to infuse and accelerate the electrons into a single-period of the Wakefield, it will prompt the ultra-short electron bunches with lengths shorter than the plasma wavelength. Electrons should be infused into the Wakefield with adequate primary energy to be caught and accelerated. Moreover, an articulation for the twofold layer structure velocity v f = β f c (which c is the speed of light in vacuum) pursues from the protection relations, expecting that neither electrons nor ions are warmed in the cooperation zone. The laser light is totally reflected and the energy transition kept by the photons in the moving frame is 2I c , which I is the light intensity in the double layer structure outline identified with the incident laser intensity, I , in the laboratory frame by the Lorentz transformation I = I (1 − β f )(1 + β f ). By comparing the force transitions of ions and electrons in the plasma channel, the relation for the front speed is as follows [13] :
where ρ = (m i + Zm e )n i0 implies the mass density, β f = B (1 + B); B = (I ρc 3 ) 1 / 2 , m i and m e imply the momentum of ion and electron, respectively, Z implies the atomic number, γ f implies the gamma-factor, n i0 implies the upstream ion density, and c implies the speed of light in the vacuum. Eq. 3 indicates the relationship between laser intensity and the mass density, which can be used to describe different environments. Fig. 2 (a) showed the proposed simulation of laser intensity in the air and Fig. 2 (b) illustrated the laser intensity of our procedure implementation in the plasma based on their mass density, for −1 < γ f , β f < 1.
As plasma is denser in comparison with air, the laser intensity in plasma is clearly stronger than in the air [9] . Hence, using Laser-Plasma interaction to accelerate particles in Hadron therapy can enhance the energy of the transferor particles, and consequently, can improve the cancer treatment, which is discussed in the following sections. Aimed at treating cancer with particles in the Hadron therapy, short, bright, and superb quality of high energy beams is required to transmit admissible dose of a particle to the cancerous target with a minor, and even no damages to the surrounding tissues. The accelerate level up in the improvement of high-intensity laser-plasma frameworks has stretched out our capacity to contemplate the light-matter interactions far into the relativistic space. By doing so, the electrons are headed to speeds near the speed of light. Just as being of principal interest for their very own right, these interactions empower the age of high-energy particle beams being short, brilliant and have great quality. In addition, high-energy ions have some advantages such as upgrading in the size, cost, and the repetition rate of high-intensity laser-plasma. The extraordinary qualities of laser-driven particle beams are required to be valuable for a wide scope of settings, particularly the malignancy treatment with particles [26] . Subsequently, accelerating particles with laser-plasma accelerators may include acceptable results for cancer treatment.
D. LASER BEAM DESCRIPTION IN THE PLASMA CHANNEL
Hadron therapy provides potential physical and biological advantages in the treatment of localized tumors. Treatment with Hadrons involves disease control in a wide variety of cancers. Hadron therapy is a non-invasive and non-toxic cancer treatment method with minimal side effects compared to other cancer treatment approaches such as chemotherapy and surgical methods. It also reduces the probability of damaging the surrounding healthy tissues and organs. No interaction exists between tissue and laser beam in Hadron therapy; hence, there will be no risk of thermal damage. In other words, in Hadron therapy, the laser beam does not proceed through the patient's body; instead, the Hadron beam goes forward through the tissue and organs, which brings no thermal damage.
Laser-driven accelerators, Particles are accelerated by an intense laser-driven electrical field of a plasma wave, Demonstrated hundreds of GV m s accelerating electrical fields [27] . Such fields are thousands of times higher than those in conventional accelerators for RF, Stimulating interest in the next generation of laser accelerators as compact sources of energetic electrons and radiations. However, acceleration distances should be strengthened by an efficient and controllable method to extend the acceleration distance of the focused and guided laser pulse. The good-quality laser beam focusing and guiding in plasma channels relies on the fine tuning of the incident laser parameters with channel parameters [28] . Optimizing the laser beam focusing and guiding is of great importance for the plasma channeling [29] . Therefore, the properties of laser beam focusing and laser beam guiding are respectively presented over long distances in this section.
1) LASER BEAM FOCUSING
Numerous approaches have been designed to guide the focused laser over a distance longer than the Rayleigh length. The distance, over which a laser beam propagates in a vacuum, is limited by the Rayleigh length and defined as [30] :
where, Z R represents the Rayleigh length, w 0 represents the radiation radius at the focus of a beam, and λ represents the laser wavelength. In Laser-Plasma accelerator, the plasma plays the role of a convex lens, focusing the laser beam towards the propagation axis. Such a mechanism is known as ''Self-Focusing'', which can balance the laser diffraction. Relying on this scheme, a powerful laser can be guided over the pump depletion length, over which, the driving laser becomes depleted, several millimeters long. To achieve self-focusing, the laser power should exceed the critical power, given by P c (GW ) = 17ω 2 0 ω 2 p , increasing rapidly when the plasma density is recued.
As an example, based on the previous term, for a plasma density n p = 1 × 10 18 cm −3 , which is proportional to plasma frequency (based on Eq. 26), P c equals 30TW . It should be noted that once this threshold is exceeded, in the laser-plasma dynamics, self-focusing plays a major role as the time-scale at which it works is much shorter than that connected with ponderomotive effects [31] . Self-focusing is the product of modifying the plasma density by the front of the laser pulse to create a density structure capable of compensating for the diffraction behind the pulse. A density structure acting to compensate diffraction can be formed prior to the intense laser interaction. A plasma channel can be created by a laser pulse. The on-axis plasma electrons move outward due to the radial hydrodynamic expansion, which will result in an on-axis density depletion and a nearly parabolic transverse density profile.
A parabolic plasma channel can guide a beam with a constant spot size w 0 = w m , where w m depends on the curvature of the channel. Being used in Hadron therapy, sometimes the laser radiation beam should be focused onto a very small spot. The laser beam can be usually focused on a diameter approaching the magnitude of the wavelength, λ. Such a spot is so small to be reached with incoherent light. Thus, we can use laser radiation to achieve an extremely high intensity. Radiation diameter in the focus, 2w 0 , is given as [30] :
where, λ implies the radiation wavelength, F # implies the F-number of the lens, f implies the lens focal length, and D implies the laser beam diameter on the lens. Table 2 indicated the radiation diameter value in the focus in case of different types of laser classification according to the parameters mentioned [32] - [34] . Some items for each classification of laser types were examined in this table. This table is defined based on the input parameters as the approximate operational wavelengths, λ, and an optimal value of F-number of the lens, F # , which represents the output results as the range of radiation diameter in focus, 2w 0 . As mentioned, in some Hadron therapy cases, we need to have a precise focusing on a small spot; therefore, minute radiation parameter seems to be an important trait. As can be concluded from Table 2 , short-pulse lasers in µm-scale wavelengths are a pioneer in fulfilling focused laser beam into a very small spot. In addition, the short-pulse lasers, like chemical lasers, are used in high-energy approaches to generate sufficient initial energy. As an example, the radiation diameter is approximately in the range of between 2.3 − 2.4 µm in a system based on Hydrogen fluoride laser at the range of 2.7 µm ≤ λ ≤ 2.9 µm, which is an ideal value. Hence, the goal of precise and miniature Hadron therapy can be realized by using laser schemes with µm-scale or even fewer wavelengths and appropriate F-number. As a result, the use of ultra-short laser in Laser-Plasma accelerator leads to precise and localized cancer treatment due to the µm-scale radiation diameter in the focus.
2) LASER BEAM GUIDING
Laser beam guiding can be defined as steering the photon beams through a specific environment to reach the destination with no deflection. Optical guiding of short and intense laser pulses in plasma channels can be used in a variety of applications, including plasma-based accelerators. In the laser Wakefield accelerator, plasma wave excitation requires laser intensities on the order of 10 18 W cm 2 [35] , and based on Eq. 5, implies µm-scale spot sizes for TW -level laser powers (Z R ∼ = 300µm, for w 0 = 10µm and λ = 1µm).
Hence, high energy gains from electrons involve guidance over lengthy distances of acceleration. Consequently, miniature lase focusing spot, shown in Table 2 , can improve the laser guiding mechanism in cancer treatment by Hadron Therapy.
The proposed plasma channel is presented as a means of guiding laser pulses. The index of refraction in a plasma density, n p , indicates approximately η R = 1 − ω 2 p 2ω 2 0 , where, ω p indicates the plasma frequency, and ω 0 indicates the laser frequency. If the index of refraction peaks on the axis, ∂η R ∂w < 0, a plasma channel can provide optical guiding which can be obtained by a plasma density profile with a local minimum on the axis, ∂n p ∂w > 0. Specifically, a channel with a radially parabolic density profile of the form n p (w) = n 0 + nw 2 w 2 0 , can guide a laser pulse with a constant radiation radius w 0 , provided that the channel depth n, satisfies n = n c , where, n c = 1 πr e w 2 0 shows the critical channel depth, and r e = e 2 m e c 2 , shows the classical electron radius, also, e and m e , show the electron charge and mass, respectively [35] .
Among the possible methods of extending the propagation length at low plasma density, called cold plasma, the laser guiding by grazing incidence reflection at the wall of dielectric capillary tubes benefits from several advantages. Lowering the plasma density increases the acceleration distance if the laser intensity is maintained at the required level over the whole distance. This can be done by guiding the laser beam capillary tube. In using a capillary tube, the laser beam is guided by reflections at the inner capillary wall; thus, laser guiding can be realized in vacuum or at a low plasma density. This guiding scheme does not rely on laser power or plasma density, which allows us to explore a large domain of laser plasma parameters. Laser guiding can, in principle, be obtained inside capillary tubes with total or partial reflection at the inner wall depending on the tube wall material, which can be either a conductor or a dielectric material. Metallic tubes can be used to guide the laser beam without loss at the inner wall. Typically, their surface is not optically smooth for the laser wavelength and the tube diameters are used for laser guiding at high intensities. Dielectric capillaries, such as glass capillaries, are optically smooth and can be manufactured with good reliability for a large range of inner diameters and wall thicknesses and lengths [28] .
III. HADRON THERAPY PROCEDURE BASED ON LASER-PLASMA ACCELERATORS A. FIVE STEPS OF HADRON THERAPY
In clinical radiation treatment before applying a laser accelerator, five steps should be considered to satisfy the clinical prerequisites and to limit any unavoidable hazards for the patient. First, laser accelerators should be created, which convey a characterized number of ions inside the restorative energy run with adequately steady and reproducible ion beam parameters. Second, a framework for beam transport and conveyance is required for cleaning the beam from undesired particles and for guaranteeing the beam energy, beam intensity, beam direction, and the field size to convey an endorsed dose to the patient [36] .
Third, an exact dosimetric control is another clinical usage which is employed in the radiation treatment requests. The clinical application results in building up a few dosimeters. The frequently utilized ones are the ionization chambers for observing, yet additionally for the supreme dose estimations. The optimal simulated irradiance dosimeters are utilized for extraordinary examinations of the framework semiconductors for relative dose estimations and a few review dosimeters. The built-up dosimeters should be explored for similarity with laser-driven beams; for example, light emissions and high radiation pulses. On the other hand, important new dosimeters should be created, which most likely need more exertions as adjusting existing ones [36] .
Fourth, one of the two methods would be utilized to convey the dose in the clinical irradiation, which is pencil beam checking or the scattering strategy. In some researches, the pencil beam filtering is, in fact, the more difficult one, yet, it permits higher tumor similarity of the conveyed dose; thus, it seems to have an expanded clinical application. For pencil beam filtering, the tumor volume is subdivided into a few ten thousand voxels, which are irradiated progressively, one voxel at once with tight mono-energetic light emissions energy and intensity over a treatment time of a couple of minutes. The latest structure of laser-accelerated ion beams with the low pulse repetition recurrence requires another system for dose delivery in the beam of the fact that the dose should be conveyed inside at any rate the equivalent (or perhaps shorter) treatment time by a much lower number of pulses contrasted with the regular ion beams [36] .
Fifth, the laser-based acceleration leads to pulses with high pulse dose rate near the source which may cause an altered radiobiological like a response. Followed by in-vivo studies with animal irradiations and by different normal and tumor tissue cell lines, it has to be first investigated by in vitro studies. In the treatment planning system, different radiobiological effectiveness also needs more effort for implementation [36] .
B. DOSE DELIVERY PROCEDURE AND DOSIMETRIC EVALUATION; IMPLEMENTATION
A productive answer for a compact accelerator to transmit the particles to a patient is provided using powerful laser pulses to light thin foil sources creating a plasma channel. Electrons in this plasma rise up out of the back surface of the source, inducing strong electric fields, which at that point shift the particles for transmitting to the objective [20] . The shot of tumor destruction with radiation relies on tumor-related factors; such as, radiosensitivity, absorbed dose pattern and morphology, and dose-response relationship, which depict the adjustment as a result on a creature, brought about by contrasting dimensions of dosages to a driver after a specific exposure time, which are the factors identified with the dose delivery modality [37] . Higher doses of radiation in Hadron therapy, for the most part, give enhanced local control and potentially longer disease-free survival. However, they guarantee that the radiation of adjacent healthy tissues is not major. Hence, the dosimetric estimations of Hadron therapy are an important enhancement to the radiobiological in the characterization of Relative Biological Effectiveness (RBE) of therapeutic beams [38] .
Finally, it can be concluded that the absorbed dose of radiation in the cancerous tissue is important in Hadron therapy, which means, the treatment process is ineffective for less amount of the absorbed dose of radiation, and consumedly amount of absorbed dose can harm the surrounding tissues.
With laser-driven beams, the manner in which pencil beam checking is done at conventional accelerators would result in longer treatment times due to their low pulse repetition rates (Maximum 10 Hz). A promising way to reduce the treatment time is to adjust the filtering technique so that the groups of a few voxels are lighted on the double. These bunches can be set up by adjacent voxels in the beam direction (axially) or along the side or by a blend of both. While laterally clustering needs bigger beam spot measures, the axial clustering requires a more extensive energy width of the beam [36] . A dose-depth profile of ion beam is generally a plateau-like curve, which closes unexpectedly with a noticeable most extreme called the Bragg peak arranged at the objective position.
In contrast, electrons and photons stored the major energy close to the start of their Bragg peak followed by a decline in their dose curve with separation as far as possible up to the objective being indeed the tumor in the radiotherapy.
The tumorous tissue should be demolished to stop the uncontrollable generation of the clonogenic cells and the ions can mostly accomplish this through atomic and ionizing collisions with the tissue [39] . The Bragg peak is a noticeable peak on the Bragg curve plotting the energy loss of the ionizing radiation amid its movement through the tissue. In the case of protons, α-rays, and other ion beams, the pinnacle happens prior to the particles' stop. Moreover, the Bragg curve is ordinary for heavy charged particles and depicts the energy loss of ionizing radiation amid movement through the tissue [10] .
1) RADIOSENSITIVITY
Radiosensitivity is a factor related to the dose delivery modality, which describes the relative susceptibility of tumors due to the injurious action of radiation [40] . The differences between tumors on the sensitivity to the beams should be studied specifically by the radiotherapists, pathologists, and the clinicians. Radiosensitivity depends on tumor properties. The value of radiosensitivity varies in different types of tumors. Some tumors are high-radiosensitive and some tumors are low-radiosensitive. Here, the tumors are classified in a decreasing order of radiosensitivity as follows: (1) Lymphoma, (2) Embryonal tumors, (3) Cellular anaplastic tumors, (4) Basal cell carcinoma, (5) Adenoma and adenocarcinoma, (6) Desmoplastic tumors, such as squamous carcinoma and fibrocarcinoma, and (7) Fibroblastic sarcoma, osteosarcoma, and the neurosarcoma. Consequently, the radiosensitivity factor is a unique feature for each tumor model, which properties may change in different surroundings. In addition, the radioresistant tumors can be generally cured by being exposed to the high-dose nearby radiation treatment, yet the broadly metastatic radiosensitive tumors should be controlled locally. In-vitro models have been created to anticipate and investigate the tumor cell radiosensitivity. The cell radiosensitivity is relatively defined based on the dose deposited in tumors, which is represented as an exponential equation [41] . Dose delivery indicates a key issue in the full therapy process with Hadron therapy since it permits the change of the beam turning out from the accelerator into a clinical dose circulation, which should be conformed to the medicinal prescription [42] . The dose deposited in the tumorous tissue, D, is the most important physical quantity in the radiotherapy and can be defined as follows [43] :
where dε represents the mean energy, V represents the value deposited by ionizing radiation in a volume element, and ρ represents the mass density. Additionally, radiosensitivity can be expressed by a linear-quadratic expression [44] :
Based on Fig. 3 , the ratio γ /λ represents a measure for the variation of the radiosensitivity per dose deposited in the tumor and takes typical values of 1 − 3 Gy for cells with lower destructive potential (Malignant), also close to 10 Gy for more destructive cells (Benign), which, is expected less radiosensitivity for low destructive potential cells and more radiosensitivity for more destructive cells. Furthermore, according to Fig. 3 , as the value of γ /λ increases, the slope of the sensitivity graph will be increased. Accordingly, the radiosensitivity increases in Hadron therapy as the absorbed dose rises. Further, the ratio of radiosensitivity and absorbed dose is nonlinear and ascending, and as the ratio γ /λ increases, the velocity of radiosensitivity variation will be raised.
2) ABSORBED DOSE PATTERN AND MORPHOLOGY OF FOUR TUMOR SHAPES
Absorbed dose in a tumor is a factor related to the dose delivery modality. This section aims to evaluate the usefulness of morphological properties in the precision of suitable dose delivery to the tumor. The morphology of cancer refers to the cancer histological classification and the description of the development course, based on which, a tumor is called ''Benign'' or ''Malignant''. It is generally acknowledged that tumors advance by the clonal choice of the cell masses, which multiply in an unconstrained method, collect changes, and seek the supplements or space. In the present worldview, the malignant growth tissue turns out to be progressively forceful, locally ongoing, and finally metastatic due to the transformation in the basic qualities [45] . In order to precisely investigate the absorbed dose in the benign and malignant tumor samples and their treatment based on Hadron therapy, the authors have detected the morphology of tumors based on the samples in the datasets [46] by using fractal analysis. The diagnosis of tumor type, as a benign mass or malignant tissue based on their morphology, can be evaluated by calculation of some indexes such as Index of Spiculation, Index of Lobule, Fractal Dimension, and the Circularity.
The ''Index of Spiculation'' indicates the dimension of spiculation and is derived from the expansion parts of the Algorithm 1 Tumor Morphology Detection 1-Input: A set of training samples from Datasets; 
N ; The number of self-similar pieces in the pattern or object 1 r; The magnification factor (e) Calculate Measurement of Circularity (C):
Stands for the area of the mass P; stands for the perimeter of the contour turning capacity, while the ''Index of Lobule'' refers to the sunken bits of the shape. Fractal dimension is an element to portray the state of a polygon. Likewise, the ''Circularity'' can be utilized as a component to describe the closeness to a hover of a locale [47] . The pseudo-code of our selected tumor morphology detection algorithm is summarized based on the fractal analysis in Algorithm 1 by Mathematica software.
One exceptionally encouraging approach gives off an impression of being a blend of fractal analysis to give a quantitative depiction of the shapes with radiographic imaging which can segregate the threats from benign tumor masses as well as from the ordinary tissue structures [48] . Fractal analysis was helpful in image processing for characterizing shape. A fractal is a capacity or example that has self-similitude by any means (or a few) scales or dimensions of amplification implying that the fractals are unpredictable geometric objects with limitless settling of the structure at all scales [46] .
With a dataset comprising of 111 contours of a combination of typical and atypical masses and tumors, FD (Fractal Dimension, for Fractal Classification) showed an accuracy comparable to other shape features [49] . Consequently, other studies indicate that it helps to separate the malignancy of tumors from the shape anomaly in the clinical centers. Totally, the threatening masses indicated more deviation from an ideal circle than the normal masses. This was consistent with the normal conduct of the threatening mass classifications as having unpredictable shapes, while the benign mass classes are generally alluded to have an oval shape [49] . Therefore, based on the recent statements, the round-shape with the customary limit tumor is related to benign masses, while malignant tumors regularly display sporadic shape with not-well characterized limits. Additionally, Fig. 4 illustrated the approximate shapes of tumors from benign to malignant, originated from the mentioned indexes. Moreover, the range of colors in Fig. 4 represented the absorbed dose intensity in a tumor shape based on Eq. 7, which describe the radiosensitivity as a factor related to the dose delivery modality as mentioned generally in terms of absorbed dose for different values of γ λ. In addition, the arrows (↓) on the top of the plot legends demonstrate the approximate absorbed dose for each tumor type, which is at its maximum (red) for the plain benign tumor ( Fig. 4(a) ), and the minimum (whitish) for the complicated malignant tumor ( Fig. 4 (d) ).
A precise system for morphological-based dosimetric verification is important in the cancer treatment based on Hadron therapy approach. Accordingly, the treatment geometry and dose delivery concepts have to be accurately defined. Benign masses appear smooth in the boundary and round in shape whereas malignant tumors appear as spiculate or microlobulate in the boundary and irregular in shape. The colors in four tumor shapes are specified in a range of −1 to 1 from blue to red, which indicate the absorbed dose in different segments of tumor shapes. As an example, red represents the maximum value of the absorbed dose, while, white shows the lack of absorbed dose. Moreover, blue displays negative values, which is undefined. In addition, the colors in this section are appointed based on Eq. 7 and the variation of γ /λ. We used spherical plots to draw the schematic of benign and malignant tumors in Fig. 4 , representing the shape of tumors in different stages of cancer under the radiance of a hadron beam unit with the same radiation angle before the onset of the treatment. Formations in Fig. 4 are the approximate forms of cancer tumors based on the fractal geometry, which are perceived from mentioned results about tumor morphology classifications for different values of γ /λ in Eq. 7. Additionally, based on the previous statements and according to γ /λ ratio in Eq. 7, as the structure of tumor becomes complicated, the tumor changes to less destructive knowing that the plain tumors are more destructive. As shown in Fig. 4(a) , the tumor morphology is uncomplicated for a benign tumor in the early stages. In addition, based on Fig. 4(b) , the tumor morphology becomes more complicated for an advanced benign tumor. In addition, for malignant tumor shown in Fig. 4(c) , the tumor structure is complex and as presented in Fig. 4(d) , the tumor frame is completely intricate.
Therefore, as the tumor structure changes to being complicated, its surface becomes uneven, and as a result, its absorbed dose pattern becomes non-uniform with multiple porosities. Consequently, getting the proper dosage to cancerous tissue is hard and imprecise in advanced stages. Additionally, as illustrated in Fig. 4(c) and Fig. 4(d) , the absorbed dose is minimal and insufficient in some deep segments. Moreover, revealed by the plot legend beams for each figure, the absorbed dose decreases as the tumor shapes become more complicated. Fig. 4 (e) illustrates the absorbed dose intensity based on the tumor shapes in Fig. 4(a) , Fig. 4(b) , Fig. 4(c) , and Fig. 4(d) , respectively. This figure acknowledged the previous results and statements. In order to sum up the aforesaid results, cancer treatment is troublesome in the advanced stages due to the complicated morphology of target leading to a non-uniform absorbed dose distribution. Eventually, the tumor morphology is an important and determinative parameter in the dose delivery process declare by the present results. Therefore, the precision of dosage is significant in the malignant tumors. The failure in the malignant cancer treatment appears as non-uniform dose delivery and the lack of absorbed dose in the deep segments during radiation.
3) DOSE-RESPONSE RELATIONSHIP
The dose-response relationship is a factor related to the dose delivery modality which affects the life form or, more explicitly, influences the risk of a characterized result created by a given measure of a specialist or the level of exposure. A dose-response relationship refers to the fact that expanding the levels of exposures are associated with either an expanding or a diminishing risk of the result. The exhibition of a dose-response relationship is seen as the strong proof for a causal connection between the presentation and the result which means that the dose-response relationship measures the connection between the amount of a substance or the introduction to radiation (the dosage) and its general impact (the response) on a living organism. The reaction may move drastically with an increment trend in dose [50] . The idea of selective radiation treatment for disease therapy developed after a while as an adjuvant to authoritative therapy of the essential site [51] .
The initial dose delivered to the tumor is determined based on the characteristics such as morphology, tumor type (Benign or Malignant), etc. However, the tumor self-repair trait in facing the initial delivered dose is unpredictable. In other words, the dose-response is a factor that demonstrates the feedback of treatment for each session of the cancer therapy and can assist doctors in making better decisions in Hadron therapy process due to the cancer treatment. Hence, it is necessary to do some research on a dose-response concept in the treatments based on Hadron therapy technique.
The endorsed dose level was then dictated to a great extent by the adequate dimension of confusions in the surrounding normal tissues. Morphologically, a tissue can be displayed as a complex of parallel and sequential structures. The volume reliance of the radiation response of a tumor principally depends on the destruction of all its clonogenic cells knowing that the tumor has a parallel structure [52] . Fig. 5 showed the response of heterogeneous tumors in different organisms for uniform dose delivery, while it is shown that a small safe clonogenic mass may cause a low dose-response gradient, γ .
Damage to tumors is a substantially more progressive and quantized process which relies upon prior impacts initiated some time before the exhaustion of foundational clonogenic cells with a more probable utilitarian association and complex basis [52] . The absorbed dose in a tumor is proportional to its morphology. Hence, the radiance pattern is designed non-uniform to better dose delivery to the complicated tumor shapes, while the radiance pattern is uniform in the case of plain tumors. Consequently, the dose delivery process is uniform for the benign masses and non-uniform for the malignant tumors. In this paper, the authors tried to evaluate the dose-response relationship of tumors for both uniform and non-uniform dose deliveries.
a: DOSE-RESPONSE OF TUMORS FOR UNIFORM DOSE DELIVERY
Eq. 8 described the Poisson statistical model of the dose delivery (P (D)) in a standard format using only the 50% of the response dose, D 50 , and the maximum value of the normalized dose-response gradient, γ ; (γ = D dP/dD). The steepness of the dose-response gradient, γ , and the 50% of the response dose, D 50 , of the dose-response relationship are derived both for a constant dose per fraction and a constant number of dose fractions. The dose-response relationship in the uniform dose delivery model is described as follows [52] :
where D shows dose, and γ shows a dose-response gradient.
Eq. 8 has a strict radiobiological foundation since it depends on the Poisson measurable model of the cell kill. The data on D 50 and γ for some representative tissues are given in Table 3 . Based on this Table, a more relevant description of a tumor in an organ is taken by partitioning it into practical or morphological subunits. Morphologically, the basic compartment can be basically all around characterized or vague. When characterizing a useful subunit, one should remember that the objective cells of a tumor are the useful ones, while the tissue cells are critical [52] . Otherwise, the dose-response relationship for tumors would depend on the organ containing the tumor located. Fig. 5 demonstrated the dose-response curve for Bladder, Colon, Esophagus, Heart, Larynx, Liver, and Lung tissues, respectively, based on the information mentioned. This figure indicates that the dose-response threshold depends on the organ that the tumor is placed on in such a way that the bladder dose-response threshold is maximum, while the threshold response for lung is minimum implying that the lung responds in a minor amount of absorbed dose in comparison with the bladder. In addition, a little compartment of the resistant tumor cells may cause a significantly shallower dose-response than a wide-spread around the mean value. The resistant tumor cells could be effectively fixed cells or the hypoxic cells remained after re-oxygenation regardless of whether the fact that the division of hypoxic cells could have been very substantial before the treatment. The hypoxic cells may be assumed to do a noteworthy job in causing a shallow dose-response for a few tumors regardless of whether their D 50 values are not impacted to such an extent. Moreover, the dose-response relationships, for the most part, rely upon the exposure time and the exposure route; evaluating the reaction after an alternate introduction time or for an alternate course prompts an alternate relationship and provides conceivably extraordinary outcomes on the impacts of the driver examined. Such a constraint is brought about by the unpredictability of the natural frameworks and the frequently obscure biological procedures working between the external simulations and the unfavorable cell or tissue reaction [52] . Likewise, the strong sequential conduct is shown by organs, for example, the esophagus, and also a stamped parallelity by the liver and the lungs in our simulation.
b: DOSE-RESPONSE OF TUMORS FOR NON-UNIFORM DOSE DELIVERY
The subsequent stage is currently to express the response of the whole organ when the dose dissemination is non-uniform with a homogeneous cell density. For the Poisson display in the non-uniform dose delivery, the circumstance is again progressively intricate and requires more detailed analysis. The response of tumors to non-uniform dose delivery is measured in the fractionated Hadron therapy by utilizing the quadratic cell survival parameters a and b. With the present information on the tumor cell survival, it would be most normal to utilize the quadratic a/b model to portray the cell survival after a complete Poisson measurable model of the non-uniform dose delivery, P(D), which is as follows [52] :
where N 0 represents the initial number of clonogens, D represents dose, D/n represents dose per fraction, a and b represent quadratic model coefficients. This model makes it possible to accurately predict the effect of the dose fractionation by replacing D with dose per fraction D/n in the non-uniform delivery model [52] . Fig. 6 illustrated the effect of the fractionation given by Eq. 9 as a function of the total dose and the dose per fraction. Based on this figure, when the radiated dose increases, likewise, the Poisson statistic model of the dose-response (P(D)) will increase. Moreover, as the fraction (n) decreases, the dose per fraction (D/n) increases, and accordingly, the Poisson statistic model of the dose-response (P(D)) would increase. In addition, the graph is ascendant and will finally change to a constant value.
4) RANGE VERIFICATION IN HADRON THERAPY
Recently, the use of Hadron therapy with Hadron beams has increased quickly around the world. Such an increasing interest in this sophisticated method of cancer therapy is due to the correct interaction characteristics of Hadron beams, which enables the concentration in a localized region of a pronounced peak dose deposition that can be adjusted in depth by altering the original beam energy [53] . This characteristic can allow the tumor to dose delivery conformal with outstanding critical organs and good tissue sparing; therefore, promising characteristics may exist such as dose escalation for enhanced therapeutic event and decreased toxicity that is a topic of growing interest for cancer tissues therapy. The recent beam delivery developments depend on beam scanning, coupled with volumetric simulation integration, more contributions have been made to enhance the possible accuracy and precision of particle beam therapy in modern treatment facilities. However, several sources of treatment uncertainties have somehow delayed the full use of the potential provided using Hadron beams in medical approaches [54] . Hadron dose verification has been observed with some particle transmission imaging systems such as Positron Emission Tomography (PET), Ion radiography and tomography, Prompt gamma, etc. This section tailored multiple ranges and dose verification solutions for better cancer treatment via Hadron therapy. Based on the results, accurate and precise range and dose verification can be obtained by implementing three parameters of radiosensitivity, dose delivery (based on morphological features), and dose-response relationship for uniform and non-uniform dose delivery.
IV. EXPERIMENTAL RESULTS AND SIMULATIONS A. LASER BEAM POLARIZATION
The existence of a preformed ion channel in a laser accelerator improves the oscillatory speed of electrons due to the restricted movements prompting the energy gain incrementally from the acceleration. The extraordinary properties of a radially polarized laser beam are used to prompt the enhancement in catching and accelerating of electron aimed at further accelerating of an electron to an extremely high energy level. The enhancement in the electron energy occurs because the radial field vanishes on the axis; yet, just the axial field endures, which accelerates the electron longitudinally. The previous studies demonstrated that the joined job of the radial polarization and the impact of an ion channel can fundamentally improve the electron energy gain [4] . The radial polarization can be depicted as the vectors of the electric field pivoted at a point in the space toward the path opposite to the plane of propagation rather than the settled orientation oscillation.
The electric field vector extent likewise stays unaltered. The radial polarization can be additionally ordered by turn [55] . Fig. 7 demonstrated the light polarization for different values of ''t'' as follows. Moreover, Eq. 11 defines the polarization [56] :
where λ: polarization wavelength, c: speed of light in vacuum, f : frequency, : polarization, d: distance between source and target, n s : polarization coefficient of the source, n t : polarization coefficient of the target. As indicated by Fig. 7 , looking at the approaching light wave, if the electric field vector of the light by all accounts seems to be turned in a clockwise way, at that point, the wave is alluded to as right-radially polarized. Then again, in the event that the light vector seems to turn in a counterclockwise direction, the wave is said to be left-radially polarized. Fig. 7(a) shows the beginning of the polarization cycle at t = 0. Furthermore, Fig. 7(b) illustrated the radial polarization of beam at t = T 2 rotating in a clockwise direction and Fig. 7 (c) indicated the polarized waveform at t = T . During the polarization, the initial waveform is permanent and the orientation also changes alternatively after each cycle; thus, the beam will shift in phase. This figure showed the phase orientation of a radially polarized light beam in terms of time changing during a cycle of ionization. In addition, the amplitude is constant during the polarization.
B. ELECTRIC FIELD EVALUATION IN THE PRESENCE OF PLASMA CHANNEL
For a system based on Laser-Plasma Channel-Charged Particle, there are different kinds of natural forces such as Electric force, Magnetic force, Ponderomotive force, Interaction force, Gravity force, Intermolecular force, etc., which emerge from several types of fields [57] . This research aimed to study the electric field due to its impact on the particle energy and energy enhancement in the plasma channel. The particle loses part of its initial energy during its traveling through the matter; therefore, the received dose may not be enough for cancer treatment. Thus, an increase in the electron energy can lead to the supply of a suitable dose of the particle to the cancerous tissue. In this case, the existence of an appropriate electric field can lead to energy enhancement. The presence of a plasma channel may apply the mentioned electric field. Consequently, the transaction between the radially polarized laser pulse and the plasma channel field limits the electron to propagate along the longitudinal direction for longer distances. As it was, the electron transverse energy is wasted because of the movement through the tissue. In this way, the pre-accelerated electrons with expansive beginning transverse energies are favored for productive acceleration [4] . Hence, in the presence of an electric field caused by a plasma channel, the initial energy reduction rate is lower than the case of electric field absence. In brief, the attendance of a plasma channel generates the electric field which may magnify the energy of carrier operators for the sake of better dose delivery. The electric field originating from the plasma channel with a radially polarized laser pulse consists of a radial (K r ), and the axial component (K z ) is presented as follows [4] :
where terms in these equations are defined as; K r : radial electric field, K z : axial electric field, K 0 : electric field in initial peak position of the pulse, r 0 : minimum laser spot size, r: laser spot size, f : frequency, ζ 0 : initial peak position in terms of x and y, ζ : peak position in terms of x and y, τ 0 : laser pulse duration, c: speed of light in vacuum, and ϕ: phase. For a firmly centered, radially polarized laser pulse, the part toward spreading electric field can deliver strong longitudinal electric field, which is assumed as an essential job in the acceleration of electrons [4] . The electric field segments along the radial and axial direction, demonstrating the qualities of a firmly centered laser pulse and attendance of plasma channel are shown in Fig. 8(a) and Fig. 8(b) , respectively. Fig. 8(a) represented the spatial profile of the radial electric field in the absence of plasma channel, which in this case, is only the electric field generated by the polarized laser and there is no indication of an axial component of an electric field specifically caused by applied plasma channel. In addition, Fig. 8(b) illustrated the spatial profile of the axial electric field in the presence of the plasma channel and indicates that the presence of a plasma channel causes the axial component of the electric field. As can be driven from these figures, the radially electric field segment vanishes at all axial points and contributes just in keeping the electron and controlling it to the broadened distance. Additionally, as shown in Fig. 8(a) , and premised on Eq. 12, Eq. 13, and Maxwell-Faraday equation, which describes the spatially varying electric field, creates an electromotive force for the points near the origin where the intensity of K r K 0 is minor and increases gradually up close to the tip and then begins to decrease. However, this process is different in Fig. 8(b) , and as demonstrated, the intensity of K z K 0 decreases in the edges at first; then, it increases and the mentioned ratio reaches to its maximum in the tip. In consequent of Fig. 8(a) and Fig. 8(b) , and previous statements, the intensity of dimensionless ratio appears to be maximum for the axial tip (in the presence of plasma channel) and the radial tip (in the absence of plasma channel) is at a low intensity.
For a closer look, in Fig. 9 (a) and 9(b), the graph was transformed into narrow strips; thus, Fig. 9 (a) and 9(b) demonstrate K r K 0 and K z K 0 ratios for different layers and the quanta of energy. As far as shown in Fig. 9 (a) and 9(b), and according to Eq. 12, Eq. 13, and Maxwell-Faraday equation, the ratio of the mentioned dimensionless parameter is maximum in the tips and minimum in the flat elements. In addition, the behavior of each element is similar to the entire graph's behavior and the general behavior of the graph is formed from the overlapping of all these strips. By turning the graphs into small striped elements, the variation rate in the intensity of the mentioned ratio will turn into constant contents. Comparing the corresponding layers and as comprehended from Eq. 12 and Eq. 13, the increased electric field intensity in each graph is obvious in the presence of the plasma channel (axial component). Therefore, in Fig. 9(a) , the intensity of K r K 0 is minor for layers near the origin increasing gradually up close to the tip layer; then, it begins to decrease up to the tip. In Fig. 9(b) , the intensity of K z K 0 decreases at first in the edge layers and then increases as well.
Finally, Fig. 10(a) and Fig. 10(b) displayed the tip magnitude of radial and axial components of the electric field in the absence and presence of the plasma channel, respectively. For a radially polarized laser pulse, the tip extent of the axial segment of the electric field (K z ) is huge when contrasted with the radial part (K r ), which is attractive for speeding up of the electrons to higher energies [4] . Fig. 10(a) and Fig. 10(b) confirmed the prior proposition. For that purpose, Fig. 10(a) shows the tip magnitude in the absence of the plasma channel and Fig. 10(b) illustrates the tip magnitude in the presence of the plasma channel. As demonstrated, the tip magnitude in Fig. 10(a) is very large compared to the tip magnitude in Fig. 10(b) . Additionally, the electric field in the tip magnitude is stronger in Fig. 10(b) in comparison with Fig. 10(a) . Therefore, one can conclude that the presence of plasma channel causes the acceleration of the electrons in higher energies, and consequently, will increase the energy, promoting better dose delivery to the target.
C. EFFECT OF PLASMA CHANNEL IN ENERGY ENHANCEMENT
In this section, authors evaluated the energetic collisions of heavy ions with the matter, including tissues using Bethe-Bloch equation and comparing the Bragg curve for three ions of Carbon, Neon, and Oxygen in the absence and the presence of plasma channel. This approach examined the maximum absorbed dose in the target via carrier ion through the matter, which can lead to the particle energy enhancement in the Hadron therapy. Charged particles, for example, protons and heavy ions lose energy when going through materials basically through ionization [58] . For this propose, the Bethe-Bloch equation was used to describe energy loss [59] . For a particle with charge z (in products of the electron charge), and the energy E, traveling a distance x into an objective of electron with a number density n and the mean excitation potential I , the relativistic rendition of the equation peruses in SI units, and the Bethe-Bloch equation is as follows [59] :
where c is the speed of light and, ε 0 the vacuum permittivity, β = u c , e and m e are the electron charge and rest mass, respectively, and [59] :
where ρ implies the density of the material, Z its atomic number, A its relative atomic mass, N A the Avogadro number and M u the Molar mass constant. ''n'' is defined as the atomic number and atomic mass for each of the mentioned ions and a factor for the differentiation of ions from each other. Therefore, the value of 'n' is minor for Oxygen ion as compared to Neon and Carbon ions. Hence, the wasted energy for Oxygen ion, as a dose transmitter, is minimum. Consequently, Oxygen ion traverses more depth in the presence of the plasma channel. The Bragg curve is a plot of the energy lack rate or Linear Energy Transfer (LET) as an element of the separation through a halting medium [60] .
In view of Eq. 17, the energy lack is described essentially by the square of the atomic charge, Z , and the converse square of the shot speed, β. This gives the Bragg curve its common place shape, cresting at extremely low energies just before the shot stops. Indeed, the Bragg peak makes particle treatment profitable over X-ray treatment for the disease [61] . β implies the ratio of the particle speed (u) to the speed of light (c) (β = u/c) and alters between 0 and 1 (0 < β < 1). Eq. 19 presents the velocity of the particle (u) as follows [19] :
where m shows the molecular mass, σ shows the electric conductivity, V shows the voltage applied across the conductor, ρ shows the density, e shows the elementary charge, s shows the number of free electrons per atom, and l shows the length of the conductor. Based on Eq. 19, the velocity is inversely proportional to the density. Therefore, the speed of the particle grows in the low-density perimeter. The density of cold plasma is about one-hundred-million electrons per cubic centimeter [9] , which is less than the air density. For this reason, the density of the perimeter in the attendance of the plasma channel is minor as compared to the lack of plasma channel. Therefore, the speed of particle increases in the presence of the plasma channel. The mentioned velocity causes a rise in the β value. Consequently, as far as Eq. 17 is established, increasing the β leads to a decrease in the value of −dE dx . Therefore, the attendance of a plasma channel reduces the wasted energy caused by an interaction between the particle and the matter. Accordingly, the effect of the presence and absence of plasma channel can be evaluated based on the β parameter variation. The stored energy can be acquired by incorporating the halting control over the whole way length of the particle while it moves in the material [62] . The initial energy of the particle was lost through its interaction with the matter. The presence of a plasma channel causes an electric field that may increase the energy of carrier operators to provide a better dose delivery to the cancerous tissue. Thus, the Bragg peak takes place in a deeper path through the target in the presence of an electric field in comparison with the electric field absence; thus, the energy dissipation through the matter decreases and the sufficient dose will be achieved.
Based on Eq. 17, Fig. 11 demonstrated the comparison of the Bragg curve manner for Carbon ion (Green), Neon (Red), and Oxygen ions (Purple) in the presence of plasma channel (electric field). In addition, this figure simultaneously shows the comparisons of the Bragg curve manner for Carbon ion (Orange), Neon (Black), and Oxygen ions (Blue) in the absence of plasma channel. Based on this figure, the Bragg peak takes place in a deeper path through the tumor target in the case of Carbon ion in the presence of an electric field as a consequent of a plasma channel (Green) compare to the case without an electric field (Orange). Thus, the energy dissipation through the matter decreases. In other words, the stopping power increases and reaches its maximum value.
In the presence of a plasma channel, the distance between the origin and the peak is longer in comparison with the absence of a plasma channel.
Additionally, the energy reduction rate reduces in the case of Neon ion in the presence of the plasma channel (Red) compared to the energy reduction rate for results obtained from the absence of a plasma channel (Black). Also, the Bragg peak takes place in a deeper path through the target in comparison with the absence of an electric field (Black). Hence, the energy dissipation through the matter decreases. For Oxygen ion, the Bragg peak takes place in a deeper path through the target in the presence of an electric field as a result of a plasma channel (Purple) in comparison with the absence of an electric field (Blue). Therefore, the energy dissipation through the matter decreases. Again, it can be concluded that the stopping power, in this case, increases and reaches its maximum value. The distance between the origin and the peak is longer in the presence of a plasma channel in comparison with the absence of the plasma channel. Consequently, the ion mentioned can pass more distances with more secondary energy to get better results in the particle transition through the matter for Hadron therapy regarding all three mentioned ions. Based on this figure, the stopping power in the Oxygen ion is less than Neon and Carbon ions for identical initial conditions in the absence of the plasma channel and the electric field. It means that, on the way of the particle through the matter toward the target, the energy dissipation of Oxygen ion is at its least; thus, this ion traverses a longer distance and transmits more energy to the target tumor. Developing Bragg peak in a longer distance, according to prior interpretation, by choosing Oxygen ion as an intended particle generates a better-transferred dose and a more proper intensity. Neon and Carbon ions have the mentioned conduct subsequently by remarkable conflict. Consequently, the Oxygen ion produces better results in Hadron therapy. Here, in the presence of a plasma channel that leads to electric field originating, the capability of Oxygen ion appears. In this condition, the optimal and desirable results happen.
D. MAXIMUM ENERGY-GAIN OF ACCELERATED HADRON IN THE PLASMA CHANNEL
We examined the energy of accelerated Hadron in a plasma channel under the combined action of radially polarized laser pulse consisting of radial axial components in previous sections. It should be noted that the longitudinal field is usually weak in the plasma channel and electrons are accelerated only by the laser [63] . In this section, first the electron energy-gain is estimated in the Laser-Plasma accelerator and subsequently compared the maximum energy of the three accelerated particles (Carbon, Neon, and Oxygen ions) in the presence of plasma channel.
Crucial studies on laser-plasma-based accelerators have provided tremendous progress in generating high-energy Hadron beams in Hadron therapy over the past few decades [7] . The particles with energies beyond 1 TeV are nowadays obtained experimentally in the industry. The high energy particle beams with intense laser pulses are essential to scale these approaches to the energy frontier of Hadron therapy and medical approaches as they can bear sufficient and controllable energy. Using less expensive acceleration technologies, make improvements can be made in heavy ion therapy. The electron energy-gain in the Laser-Plasma accelerator, W acc , can be approximately (20) where, m e represents the electron mass, c represents the velocity of light in vacuum, e represents the electron charge, P represents the laser power, n c represents the critical density, and n p represents the plasma density. This formula indicates that the plasma electron density is a key parameter for tuning the electron bunch energy; a large energy-gain over the dephasing length can be obtained for low electron density and large laser power. Fig. 12 showed the electron energy-gain, P (TW ), as a function of plasma density and laser power,n p . For a laser power of 100 TW , Eq. 20 predicted that the electrons can be accelerated up to 1.7 GeV at a plasma density of n e = 1 × 10 18 cm −3 , which is much higher than the required energy of particles and heavy ions. The energy-gain displays a stronger dependence on plasma density than on the laser power. Hence, a lower electron plasma density is desirable to achieve a higher electron energy. Based on Fig. 12 , the laser penetrates the cold plasma with minimal losses of energy due to the interaction at a lower density enabling a higher energy-gain for each particle in the presence of plasma channel compared to the absence of a plasma channel. Hence, adequate acceleration energy is gained in Hadron therapy with Laser-Plasma accelerator by using the sufficient value of laser power and plasma density. Based on Fig. 12 , the Laser-Plasma accelerator gains the maximum accelerating energy by a 100 TW laser pulse at a low density plasma (∼1×10 18 cm −3 ), suggesting a powerful laser in a low density plasma channel can lead to a high energy acceleration. The particles can obtain comparable energy from both the plasma wave and laser acceleration mechanism in the presence of a plasma channel, which leads to high energy-gain in the Laser-Plasma accelerator [7] . The breakthrough of heavy ions energy up to GeV can trigger significant advances in the medical physics. The kinetic energy of accelerated Hadron, W h , impressed with the normalized laser pulse, J , is defined as in a plasma channel as follows [64] :
where, m h represents the mass of Hadron and c is the velocity of light in the vacuum. Based on this equation, the mass of Hadron is an important parameter to gain the received dose in the cancerous tumor for Hadron therapy; a large energy-gain can be attained for heavy particles. Fig. 13 showed the proposed implementation of the energy of accelerated Hadrons in the presence plasma channel for Carbon, Neon, and Oxygen ions, respectively. In this figure, it can be seen that the kinetic energy-gain is equal to 0.09 GeV for Carbon ion with a 100 TW laser in a low density plasma channel about 1 × 10 18 cm −3 . In addition, the mentioned parameter is 0.43 GeV for Neon ion, and 0.96 GeV for Oxygen ion. As seen in this figure, the maximum kinetic energy-gain of Oxygen ion is higher than the two others in the presence of a plasma channel.
Thus, Oxygen ion transfers more energy to the tumor, which leads to better dose delivery and completes the destruction of cancerous cells, playing an efficient role in Hadron therapy. Table 4 , defined based on the input parameters as the mass of Hadron (m h ), the plasma density (n p ), the laser power (P), and the normalized laser pulse (J ), represents the output results as minimum and maximum values of the electron energy gain in the Laser-Plasma accelerator (W acc ) and the kinetic energy of accelerated Hadron (W h ). In addition, based on Eq. 21, the plasma density was considered at n p = n c in the absence of plasma channel and at 1 × 10 18 cm −3 ≤ n p ≤ 10 × 10 18 cm −3 in the presence of plasma channel to calculate the minimum and maximum values of W h for different masses of mentioned Hadrons, m h , and the normalized laser amplitude is equal to 0GV /m ≤ J ≤ 10GV /m [65] .
The results in Table 4 suggest that the maximum values of W acc and W h in the presence of plasma channel are higher than their values in the absence of plasma channel, meaning the transferor particles gain more energy in the presence of plasma channel compared to its absence, leading to the delivery of sufficient dose to the tumor, which can ablate the entire cancerous cells during the Hadron therapy process. Based on the obtained results depicted in Table 4 , the maximum kinetic energy of accelerated Hadrons for Oxygen ion is 0.96 GeV , which is higher than Neon ion and Carbon ion. Therefore, Oxygen ion gains sufficient energy more than others in the presence of a plasma channel and can deliver the maximum dose to the target, which is the optimal approach in Hadron therapy. Finally, based on the experimental outcome presented in Table 4 , and verification by another simulation modeling [1] , [66] , the use of Oxygen ion in the plasma channel generates sufficient energy for particles and supports sufficient Hadron particles to transfer to the tumor in the medical treatment. In general, the results of this section indicate that (i) there is a sharp dependence of the energy-gain electrons on the plasma density and laser power in the presence of the plasma channel. (ii) When particles are accelerating in a low density plasma (cold plasma), there is a maximum value of kinetic energy, in which, the particles gain a large amount of energy from the laser pulse and plasma wave and keep the energy after getting out of the resonance; this maximum energy is much higher for the Oxygen ion. (iii) The self-generated plasma channel can assist in laser acceleration and allow the energy-gain beyond the absence of a plasma channel.
V. CONTROL OF LIMITING FACTORS ON LASER-PLASMA ACCELERATION
Several factors can limit the effective accelerator length, and, therefore, the energy-gain in a Laser-Plasma accelerator. The energy spread is one of the strongest constraints and the two other significant limitations for a channel-guided Laser-Plasma accelerator are dephasing and pump depletion. In this section, the limiting factors of Laser-Plasma accelerators were examined followed by presenting a method to overcome the aforesaid limitations to reach the maximum energy-gain, which can lead to localized cancer treatment and an optimal dose delivery to the cancerous target in Hadron therapy.
A. ENERGY SPREAD
Energy spread caused by the longitudinal size of the beam is an important challenge in Laser-Plasma Wakefield acceleration with an emphasis on minimizing the energy spread of an accelerated electron bunch. The bunch length (L), beam loading (η) (proportional to plasma density (n p )), and the injection phase (ψ inj ) are determining parameters to reach this goal. Thus, this research described how these parameters may minimize the energy spread with providing a strategy based on the mentioned parameters to minimize the energy spread.
1) CONTROLLING BY LASER-PLASMA PARAMETERS
The energy spread is indeed the sum of two contributions; the first results from the bunch length and the second results from the Wakefield of the electrons in the bunch as a contribution to the energy spread; each electron is affected by the Wakefield's of all electrons in front of it. For small beams in a channel, the transverse beam emittance is well preserved, and the dynamics of the transverse beam has little impact on the energy-gain and energy spread. The relative energy spread ( ) depends on the three mentioned parameters as follows [67] :
where, implies the energy gain, implies the energy difference, η is the beam loading, L implies the bunch length, k implies a coefficient, ψ ext implies the extracted phase, and ψ inj implies the injected phase. As the beam loading (η) is a coefficient for Eq. 22 and instantly proportional to relative energy spread, accordingly, the minimizing of this parameter clearly leads to minimizing the relative energy spread. Therefore, the following investigations were continued by an experimental constant value of beam loading, η = 0.5, being the variation of bunch length and injection phase, and we examined their effects on the relative energy spread. Furthermore, cos(kL 2) and (ψ ext −ψ inj ) sin(ψ inj) −sin(ψ ext ) are increasing at 0 < L ≤ 3 (or [0, π]) and decreasing at 3 < L < 6 (or (π, 2π)). Fig. 14 displayed the relative energy spread after acceleration over a certain acceleration distance. This figure demonstrates the influence of bunch length and injection phase at fixed beam loading η = 0.5. Based on Fig. 14, the relativity energy spread for 0 < ψ inj < 1 is half of the relativity energy spread in the range of 3 < ψ inj < 4; hence, the graph has a damping trend. According to the figure, the range of 0 < ψ inj < 3 is not suitable for acceleration due to high relativity energy spread, which leads to a minor energy-gain. Subsequently, the ranges of 3 < ψ inj < 4 and 5 < ψ inj < 6 seem to be attractive for acceleration based on minimum values of the relative energy spread. Hence, a maximum in the energy-gain occurs in these regions. After first concavity at 3 < ψ inj < 4, it takes less time to reach the second minimum (5 < ψ inj < 6) in the energy spread. Fig. 14 showed that the relative energy spread is minimum for every value of the bunch length by tuning the injection phase approximately in π, 2π, and their vicinities. Consequently, minimizing or even eliminating energy spread can be realized by choosing the optimal values of both determinative parameters. The maximum energy-gain is reached with minimizing the energy spread occurred in the concavity region for 3 < ψ inj < 4, 5 < ψ inj < 6, and 0 < L < 6. This means that at some stage, a part of the bunch is decelerated and another part is still accelerated. The decrease in relative energy spread at 3 < ψ inj < 4 is due to the simultaneous reduction of cos(kL 2) and
at π. Moreover, the decrease in relative energy spread at 5 < ψ inj < 6 is due to the particle loss. In this case;
more balance : 3 < ψ inj < 4 and 0 < L ≤ 3 less balance : 3 < ψ inj < 4 and 3 < L ≤ 6 more balance : 5 < ψ inj < 6 and 0 < L ≤ 3 less balance : 5 < ψ inj < 6 and 3 < L < 6
Based on the above results, an optimum can be achieved by proper tuning of the beam parameters L, η and ψ inj . Based on the strategy, the beam loading is experimentally fixed and can minimize the relative energy spread by tuning L and ψ inj . By increasing the bunch length at 0 < L < 3, the relative energy spread decreases initially, and then increases at 3 < L < 6, and so, two concavities will occur. Also, by injection phase increasing, the relative energy spread follows the same process. Practically speaking, the injection phase is the most challenging parameter to adjust as it indicates a femtosecond precision in the plasma wave injection of the bunch. Solving this problem is a significant challenge for plasma-based accelerators design in the future.
2) CONTROLLING BY LASER-PLASMA ENVIRONMENT DENSITY
The use of a lower plasma density is an effective method to control the energy spread occurring at low temperatures, which is called ''Cold Plasma''. Low density plasma contains low temperature electrons; thus, the plasma density is proportional to electron temperature [68] . The development of the cold plasma mechanism leads to the rapid formation of a new plasma medicine field. Recent advancement in atmospheric plasmas has resulted to cold plasma manufacturing at ion temperatures near to room temperature, which was employed in this paper. These plasmas are therefore different from the typical low-temperature plasma of a regular electrical discharge [69] . Such cold plasmas are very helpful instruments that enable biological tissue interaction without heat damage; thus, it is an efficient approach for Hadron therapy. In the current section, we first revealed the relation between plasma density and plasma temperature in brief, and then examined the effect of cold plasma as a low density plasma on the energy spread. The electron density has been shown empirically to decrease exponentially with increasing electron temperature as [70] : log (n e ) = −2.0 log (T e ) + 0.6 (23) where n e shows the electron density, T e shows the electron temperature, and γ shows the polytrophic index, with implies that T e ∝ n γ −1 e . Eq. 23 showed that the density falls off faster as the temperature rises. This could indicate the presence of surplus particle heating mechanisms. For example, the heating begins and could be due to wave-particle interactions, parallel electric field acceleration or heat flow from above. In extremely low densities, there is a mixture of photoelectrons [70] . Further, based on Eq. 23, cold plasma made in lower temperatures has a lower plasma density. In addition, Eq. 24 defined the beam loading (η) as a function of plasma density (n p ) as follows [67] :
where, k is a coefficient, b is beam width, n p is the plasma density, n o is the background density, and A 0 is the laser Wakefield amplitude. In our implementation, Eq. 24 and Eq. 22 were integrated to show the relation between relative energy spread ( ) and plasma density (n p ), are, and therefore, the relative energy spread was rewritten based on the plasma density. Fig. 15 showed the variation of relative energy spread as a function of plasma density at L = λ 3, where λ = 2π k is the plasma wavelength, ψ ext = π, ψ ext = π 2, and kb n 0 = 1. As can be concluded from this figure, relative energy spread and plasma density, are linearly proportional. Therefore, for low plasma densities, the relative energy spread will be low and contrariwise. Finally, minimizing the relative energy spread by using cold plasma localizes the particle on the target (tumor), and the particle beam does not affect the enclose tissues. Therefore, the mentioned process can cause better dose delivery to cancerous tissue, in Hadron therapy.
In summary, both studies and the simulations of study showed that a low energy spread and high energy-gain can be achieved if the parameters L and ψ inj are properly tuned when η is a fixed parameter. In addition, based on Eq. 22 and Eq. 24, low energy spread occurs in low density plasma. The corresponding parameter window is relatively wide, with the most crucial parameter being ψ inj requiring a femtosecond accuracy in bunch injection. Foresaid statements and simulations demonstrate that the well-known energy spread problem of Laser-Plasma acceleration in Hadron therapy which can affect negatively localized cancer treatment and also energy-gain, can be solved by choosing consciously optimal values of bunch length, beam loading, and the injection phase, in a low density plasma which called ''Cold Plasma''.
B. DEPHASING DESCRIPTION
Rapid dephasing is a significant limit for energy-gain in Laser-Plasma Wakefield accelerators, after that the electron beam enters the Wakefield's decelerating region and begins to decelerate. For expansive description, consider an electron accelerated along the laser-propagation axis. As the electron is accelerated, its velocity will increase and approach the speed of light. Then, the electrons will eventually outrun the plasma wave and move into a phase region of the plasma wave that is decelerating. This limits the energy-gain of the electron in the plasma wave and is commonly referred to as electron dephasing. Therefore, the energy of the particle reduces [65] . The fundamental way to solve the dephasing issue before achieving high energies is to split the acceleration phase into various phases in each case the relative longitudinal position is readjusted between the particle and the laser [71] . In cancer treatment based on Hadron therapy, accompanied by polarized laser in a plasma channel, depending on tumor location (target) from the source, two statuses can occur. First, the distance between source and target is less than dephasing length, and second, the distance between source and target is more than dephasing length, which is more probable in cancer treatment. In the first status, the dephasing does not occur. Hence, there is no barrier to energy-gain. But in the second status, the dephasing problem occurs. In this paper, to overcome electron dephasing in the plasma channel for Hadron therapy, the dephasing length approach is investigated.
The dephasing length, L d , is defined as the length over which an electron can be accelerated before reaching a decelerating period of the electric field. Increasing the dephasing length, is the demanded approach, because the maximizing of dephasing length can improve dose delivery in cancer treatment based on Hadron therapy. In other words, maximum dephasing length is desired which means maximum traversed length before decelerating, when the electron energy is increasing in the accelerating region. In this case, particles can deliver the maximum energy to the target (tumor) before decelerating. The dephasing length (L d ) is defined as [28] :
In addition, the plasma frequency (ω p ), is shown as follows [28] ;
ω p = n p e 2 m e ε 0 (26) where, ω 0 implies the laser frequency, ω p implies the plasma frequency, a 0 implies the laser pulse envelope, k p implies the plasma wave number, n p implies the plasma density, e implies the electron charge, m e implies the electron mass, and ε 0 implies the permittivity of free space. Eq. 25 and Eq. 26 showed that the dephasing length depends on both the plasma density and the laser intensity. For demonstrating the relation between dephasing length (L d ) and plasma density (n p ), Eq. 26 and Eq. 25 were combined, therefore, the dephasing length equation is rewritten as a function of plasma density. Fig. 16 illustrated the dephasing length as a function of plasma density for different values of laser pulse envelope and laser frequency based on two mentioned equations. Based on Fig. 16 , by increasing the plasma density, the dephasing length decreases exponentially. This means, for maximizing the dephasing length which is the desired approach, low density plasma as called ''Cold Plasma'' is better than other densities.
The length of dephasing depends on the density of the plasma, becoming longer for low densities. The Wakefield period shrinks as the driving laser pulse encounters a higher plasma density, and the boundary between the accelerating and decelerating region moves as fast as the electron bunch itself, keeping it within the ion cavity at the same phase. The matching stage between the Wakefield and the bunch of electrons can be maintained for a longer range of acceleration, resulting in greater electron energies [72] . Consequently, based on our investigations and implementations, using cold plasma, as a lower density plasma, can prolong the dephasing length for transferring maximum energy to the target (tumor) before decelerating. The maximum energy-gain (W max ) after dephasing length, is roughly defined as [65] :
where, e is the electron charge, E max represents the peak field amplitude of the plasma wave, and L d represents the dephasing length. Based on Eq. 27, by increasing the dephasing length, the maximum energy-gain, will increase, which leads to maximum dose delivery to the cancerous target. Additionally, by merging Eq. 25, Eq. 26, and Eq. 27, the maximum energy-gain (W max ) after dephasing length as a function of plasma density (n p ) can be defined as;
where, all parameters were introduced already. Based on Eq. 28, the maximum energy-gain is inversely proportional to the plasma density, which means in low density plasma, the maximum energy-gain is uttermost. Therefore, by using cold plasma as a low density plasma, the maximum energy-gain increases. Thus, the rapid dephasing can be overcome as an important limiting factor of energy-gain for Laser-Plasma acceleration. Briefly, based on these considerations, applying cold plasma in Hadron therapy procedure, leads to increasing the dephasing length and energy-gain in particles, which can deliver the maximum energy to the tumor and optimal dosage in this treatment method.
C. PUMP DEPLETION DESCRIPTION
Another underlying Hadron therapy limitation is the so-called ''Pump Depletion'', associated with the length, L pd , over which the driving laser becomes depleted. As the laser pulse travels in the plasma, it transfers its energy to the plasma wave. The pump depletion length is defined as the distance over which the energy contained in the plasma wave equals that of the driving laser. Through feedback from the plasma wave on the pulse, pulse evolution will finally play an important part in the evolution of Wakefield. Some impacts such as pump depletion will always happen if the laser pulse is permitted to propagate a adequately long distance that impacts both the laser profile and the Wakefield amplitude. The pump depletion length can be estimated by equating the laser pulse energy to the energy left behind in the Wakefield [65] . The pump depletion length is estimated via the etching velocity, v etch , which was defined as [28] :
Then, the pump depletion length, L pd , given by [28] :
where, c is the light velocity in the vacuum, ω p is the plasma frequency, ω 0 is the laser frequency, and τ 0 is the laser period which defined as τ 0 = 2π ω 0 . Fig. 17 , illustrated the proposed implementation of both dephasing length, L d , and pump depletion length, L pd , as functions of plasma density, n p , by using Eq. 26, Eq. 29, and Eq. 30. Depending on this figure, the pump depletion length depends on the plasma density, getting longer for low densities. In other words, the pump depletion is postponed by using a low density plasma. Hence, the proposed way to overcome laser depletion is using cold plasma. Laser pump depletion deferring, in other words, increasing in pump depletion length, occurs in low density plasma causing more energy-gain in accelerating particles. In this case, using cold plasma, which is a low density plasma, leads to better energy-gain and better dose delivery to the cancerous target in Hadron therapy treatment. Typically, the two lengths are of the order of a few millimeters in the density range above n p = 3 × 10 18 cm −3 , where dephasing dominates pump depletion. As shown in Fig. 17 , the most efficient use of laser energy is achieved around the density where L d = L pd . Below n e ∼ = 2.5 × 10 18 cm −3 , pump depletion occurs over a shorter length than dephasing, and both lengths increase quickly when the density becomes of the order of 1×10 18 cm −3 . Pump depletion of the laser pulse energy (lost to wake excitation) also reduces the Wakefield amplitude. If the trapped electrons propagate beyond a dephasing distance, the electrons lose energy, which leads to a broad energy distribution [65] .
VI. DISCUSSION
Hadron therapy is a non-invasive and non-toxic treatment procedure to treat cancer with accelerated Hadrons. Various types of cancers with several tumor types can be treated through Hadron therapy. Therefore, it seems necessary to perform a deep study on this approach and present methods to optimize it. Generating high-energy accelerating Oxygen ions with Laser-Plasma accelerators causes efficient dose delivery to the tumor and leads to a better cancer treatment. Therefore, studying the ion acceleration concepts can describe the features of ions, which gain energy through the electric field in the plasma channel as evaluated in this research. The study of laser intensity and plasma density seems an important requirement in the treatment based on laser acceleration. Therefore, this paper surveys Hadron acceleration with an ultra-intense and ultra-short pulse laser in a plasma channel.
The damages induced by irradiation at the DNA scale are characterized by multiple bases which are affected in a few turns of DNA helix being referred to as clustered DNA damage or multiple damage sites. For additional description, the pattern of the discrete energy depositions during the radiation track passage defines the spatial distribution of lesions which is induced in DNA. Then, fractioned DNA contains the clusters of lesions being formed over a few nanometers. However, such clustered DNA damage sites, which may be considered as a detriment signature of radiation, underlie the deleterious biological consequences of radiation for killing cancerous cells [7] . As far as described in Laser-Plasma accelerators mechanism [24] , the laser beam in Hadron therapy fails at irritating the cancerous tissue directly. Therefore, the clustered DNA damages in Hadron therapy are much less than photon therapy. Furthermore, Hadron therapy through ions with high Linear Energy Transfer (LET) and minimal damages of healthy tissues, minimizes the DNA damages. From a medical point of view, three critical pathways, namely, homologous recombination, non-homologous end joining, and alternative end joining, are usually used to resolve DNA lesions through cancer treatment and which are founded on recruiting DNA strand invasion proteins [7] , [12] . In addition, human cells have developed a sophisticated signaling network-the cellular DNA damage response-, which detects and repairs DNA lesions. Such an issue significantly reduces the detrimental effects of Hadron therapy. Fig. 2 displayed the proposed simulation of laser intensity in two different environments of laser intensity in air and laser intensity in plasma. The experiment indicates that the laser beam is much more intense in a low-density plasma in comparison with air. As an example for β f = 1 and γ f = 0.5, the laser intensity in the air is approximately half of the laser intensity in the plasma. Consequently, propagating the laser beam in a low density plasma channel leads to better acceleration and causes better dose delivery to the target.
Additionally, dosimetric procedures play a key role in Hadron therapy. Section III describes the effect of radiosensitivity as a factor as the relative susceptibility of tumors due to the injurious action of radiation. Fig. 3 showed the effect of radiosensitivity variations per dose on the delivered dose to the tumor for different values of γ λ. Based on proposed simulations, the benign tumors are more radiosensitive and malignant tumors are less radiosensitive; hence, in identical treatment term, the dose deposited in the malignant tumor is less than the benign tumor. This discrepancy on tumor types is the basis for planning cancer treatment via Hadron therapy. Tumor morphology based on the tumor type is another important factor in dosimetric evaluations. Estimation of tumor morphology through Algorithm I and the results of the proposed implementation in Fig. 4 showed that the absorbed dose pattern on malignant tumors is completely non-uniform and week for tumor shapes, which are complicated. Hence, using a non-uniform particle beam, which changes based on the tumor morphology, by proper azimuthal radiation angle leads to a precise cancer treatment. Complete reduction of cancerous tissue is another utility of tumor shape estimation method. This procedure causes optimal beam radiance parameters for cancer treatment via Hadrons.
After that, the role of a dose-response relationship for uniform and non-uniform dose delivery was described in this research. The proposed simulation in Fig. 5 showed that the treatment results are absolutely influenced by the tumor location in different organisms. Based on this figure, the dose delivery procedure can be controlled relying on the target organism. In other words, the feedback of treatment proceedings can be estimated by the tumor location in the patient's body, and therefore, the proper amount of dose can be selected. Moreover, Fig. 6 showed that in non-uniform dose delivery, by increasing or decreasing the radiated dose, the dose-response will change. The proper dose is not limited to a specific range and changes during different cases. In other words, the appropriate dose will change for each patient and different kinds of tumors with several traits. Hence, in this paper, appropriate methods like as Radiosensitivity, Absorbed Dose Pattern and Morphology of Four Tumor Shapes, and Dose-Response Relationship were demonstrated for uniform and non-uniform dose delivery to evaluate the optimal dose delivery.
However, realizing the laser beam conduction may subsequently lead to better dose focusing and guidance. In this way, utilization a radially polarized laser beam for better Hadron acceleration was described expansively in our research. Author's implementations in Fig. 7 showed that changing the time shift in a laser beam changes the phase shift, and consequently, changes the manner of polarization. Moreover, the result of this section showed that the polarization variation in the plasma channel changes the speed of electrons due to the restricted movements prompting the energy-gain incrementally from the acceleration. High-speed electrons in the plasma channel cause better cancer treatment through high-energy hadrons, which can travel through the patient's body to the cancerous target with a sufficient dose.
Employing the polarized laser beam in the performed plasma channel generates an electric field, which requires to survey the electric field evaluation in a plasma channel. The proposed simulation in Fig. 8 and Fig. 9 compared the spatial profile of the electric field in the absence and presence of a plasma channel. Based on these figures, the presence of a plasma channel makes the electric field stronger, and consequently, an intense electric filed generates high-energy particles for Hadron therapy leading to a better dose delivery. Additionally, our results in Fig. 10(a) and Fig. 10(b) show that the tip extent of the axial segment of the electric field is huge when contrasted with the radial part, which is attractive for accelerating of the electrons to higher energies. Hence, using a radially polarized laser beam and a plasma channel simultaneously leads to energy enhancement being one of the important aims of the author's research. The energy loss through the body leads to the shortage of delivered dose, which causes incomplete cancer treatment and some cancerous tissue will remain. Therefore, the proper dose will deliver to the target by enhancing the initial energy of Hadrons in the plasma channel.
Basically, the effect of plasma channel in energy enhancement was investigated to present an innovative and effective manner for better dose delivery to the tumor. This paper showed that using Oxygen ion as a transferor particle in a plasma channel, accelerated by a radially polarized, ultra-short, and ultra-intense laser beam, and leads to an acceptable path length of more than 40 cm through the body. Accordingly, Fig. 11 illustrated the Bragg curves of three ions; Carbon, Neon, and Oxygen. In comparison with other state-of-the-art papers, based on this figure, this research showed that using Oxygen ion in a system based on accelerating Hadrons in the plasma channel by radially polarized laser beams with ultra-short and ultra-intense pulses can solve the problem of energy-loss as Hadron passes through the inner tissues and the shortage of received dose in the target. The structure of tissue is multi-layer. Thus, not enough penetration range is probable in laser-tissue interaction for laser-induced medical applications in some cases such as photo-thermal therapy, and photo-dynamic therapy. Here, due to the nature of the radiation in Hadron therapy, laser beams fail at interacting with tissue directly and irritating the tumor. Thus, the traverse of hadron beams through multi-layer tissue for arriving to the tumor is one of the advantages of cancer treatment based on Hadron therapy [24] . In this study, Fig. 11 indicates that accelerated hadrons are the intended particles which travel through the patient's body using Oxygen ion for transferring energy to the tumorous tissue, which can traverse over 40 cm through the body. The Bragg curve can be defined in terms of Linear Energy Transfer (LET). In particular, the Bragg curve is the LET being delivered to the tissue, as a function of the distance through a stopping power medium. It can be also noted that the terms of LET are used for indicating the average amount of energy which is lost per unit path-length as a charged particle travels through a given material. In other words, LET is related to stopping power, since both Bragg curve and LET are relevant on the retarding force [7] . Based on Fig. 11 , between three proposed ions, the retarding force affecting Oxygen ion per centimeter is less than Carbon ion and Neon ion. A high LET ion will attenuate the radiation more quickly, generally making shielding more effective and preventing deep penetration and the received dose will increase [7] .
This study demonstrated that the energy-gaining can be achieved in a cold plasma with a high-power laser pulse, which is shown in Fig. 12 , and the maximum acceleration energy near 1.7 GeV was generated with Laser-Plasma accelerator. Then, in Fig. 13 , it was shown that the kinetic energy gain of Oxygen ion is more than twice bigger than Neon and Carbon ions. The kinetic energy-gain of Carbon, Neon, and Oxygen ions are calculated as 0.09 GeV , 0.43 GeV , and 0.96 GeV , respectively. Consequently, the outcomes depicted that the energy enhancement and the optimal dosimetry can be realized by using Oxygen ion, as a transferor particle in the cold plasma channel being accelerated by utilizing radially polarized laser beams with ultra-short and ultra-intense pulses. Therefore, achieving these experimental results can improve the quality of the cancer treatment based on Hadron therapy.
Controlling Laser-Plasma acceleration limitations is an important challenge for increasing the acceleration length generating high-energy particles for Hadron therapy. The results of Fig. 14 and Fig. 15 demonstrated that the energy spread limitation can be controlled by choosing the optimal value of three laser-plasma parameters, including bunch length, beam loading (proportional to plasma density), and the injection phase. Subsequently, in Section V, some optimal ranges were demonstrated for mentioned parameters where the relative energy spread was minimum in the cold plasma channel. Minimizing or even eliminating the energy spread causes the energy-gain and provides the localized tumor treatment in Hadron therapy. Fig. 16 , illustrated that the dephasing limitation can be controlled by choosing cold plasma and the Hadrons gain more energy in the Laser-Plasma accelerator that causes high-energy acceleration; therefore, the hadron beam can go through the path with much more energy. In addition, this research showed a similar result for controlling the pump depletion as well as dephasing by using the cold plasma. Consequently, the main mission in this paper was to find the ways for a better dose delivery in the cancer treatment based on Hadron therapy by using cold plasma to control the Laser-Plasma limitations. Eventually, Fig. 17 showed that in this research and experimental results, the best mode for Hadron therapy happens when the dephasing length and a pump depletion length are equal (L d = L pd ).
VII. CONCLUSION AND PROSPECTIVE WORKS
Hadron therapy speaks to the significant commitment to the treatment of patients and many fascinating improvements at the forehand edge of science and innovation advancements. Treatment with hadrons can create persisting loco-local sickness control in a wide assortment of malignant cancers such as head and neck cancer, prostate cancer, ocular tumors, gastrointestinal tumors, esophagus cancer, hepatocellular cancer, non-small lung cancer, central nervous system tumors, sarcomas, pelvic tumors, cervix tumors, and the bladder cancer. Hadron therapy produces more noteworthy disease-free survival, targets tumors and malignancy cells with exactness and minimal exit dose, and largely decreases lethality and toxicity, and correctly conveys an ideal radiation dose to the tumor which enhances personal satisfaction amid and after the treatment in contrast with other treatment techniques. Laser beam focusing and laser beam guiding are important parameters to localize the laser beam on a specific spot through the tissue. Based on proposed results and simulations, using ultra-short pulse lasers with µm-scale wavelengths leads to a miniature radiation diameter in focus which is a necessity for accurate and precise medical aims. If the index of refraction peaks on an axis, which can be accomplished with a plasma density sketch with a minimum local axis, a plasma channel can provide optical guidance. In addition, the dielectric capillary tubes are suggested for guiding laser through the plasma channel. In capillary tubes, the laser beam is guided by reflections at the inner capillary wall, and laser guiding can be achieved in vacuum or at a low plasma density.
Ions provide essential applications crosswise over interdisciplinary fields, including Hadron therapy, the combination inquire about, a space program, etc. The particle transport material science is the central shared factor in every one of these applications with atomic and plasma-material science as the foremost fixings. In contrast with photon or electron beams utilized in the traditional radiation treatment, high-energy ion beams offer desirable conditions for the treatment of deep situated surrounding tumors. Their physical depth-dose distribution in tissue was defined by a little passage dose and a distinguished maximum (Bragg peak) close as far as possible of a range with a sharp descent at the distal edge. The well-defined range and the little parallel pillar spread make it conceivable to convey the dose with millimeter exactness. Ions, furthermore, have improved biological adequacy in the Bragg peak district being brought about by the thick ionization and the subsequent diminished cell fix rate making them appropriate for the treatment of the radio-resistant nearby tumors.
This paper began with demonstrating that laser intensity in a plasma channel is stronger compared to the air perimeter. The trait mentioned causes an increase in the electric field, which leads to better particle acceleration, and consequently, a better cancer treatment. Then, multiple procedures were studied for better dose delivery to the cancerous tissue for the cancer treatment process. Thereby, we investigated the relationships between the effects of Radiosensitivity, Tumor morphology, and Dose-response. Additionally, this paper showed less radiosensitivity for less destructive tumors and more radiosensitivity for more destructive tumors per identical amount of received dose at equivalent radiation angles. In addition, it was indicated that the tumor morphology is an important and determinative parameter in the dose delivery process. Moreover, the precision of dosage is significant for malignant tumors with complicated structures and ions as energy transmitters is a suitable approach. Furthermore, the effect of uniform and non-uniform dose delivery on the dose-response of tumors in terms of parallelity and seriality was discussed and examined.
The researchers surveyed Hadron therapy methods and the effect of energy enhancement for better particle acceleration in this paper. The pre-accelerated electron acquires energy in the presence of a plasma channel because of the axial electric field part of a radially polarized laser pulse since the radial segment vanishes at all focuses on the axial axis. The spatial profile of the electric field segments of a radially polarized laser pulse demonstrated that the extent of the axial electric field is much bigger than the spread electric field which is attractive for electron accelerating. The interaction between the radially polarized laser pulse and the electric field of plasma channel limits the electron propagation along the longitudinal bearing for longer distances. In this way, the electron increases adequate energy due to the coupling of electron transverse movement with the longitudinal electric field. The electron transverse energy is discharged because of a strong longitudinal electric field. Along these lines, the pre-accelerated electrons are favored with expansive starting transverse energies, for proficient accelerating. Hence, the presence of a plasma channel causes energy enhancement. Then, the Bragg curves of the three ions of Carbon, Neon, and Oxygen illustrated and compared. Further, it was demonstrated that Oxygen ion is a proper particle in Hadron therapy due to its minor energy dissipation through the matter on the way to the tumor where it can deliver the maximum amount of energy to the cancerous target. Finally, to sum up the aforesaid statements, it can be said that the capability of Oxygen ion appears in the presence of a plasma channel leading to an electric field impressed by a radially polarized laser accelerator. The optimal and desirable results happen under such conditions. Multiple simulations are proposed to attain the maximum energy of accelerated Hadron in a plasma channel. Based on presented results and simulations, the energy-gain is inversely proportional to plasma density and directly proportional to laser power. Hence, adequate acceleration energy occurs for a better dose delivery in Hadron therapy by using the sufficient value of laser power in a cold plasma channel, which has a low density. Moreover, this paper indicated that Oxygen ion could attain more accelerated energy in comparison to Carbon and Neon ions in the presence of a plasma channel.
Three limiting factors of Laser-Plasma accelerators were presented in this paper, including ''Energy spread'', ''Dephasing'', and ''Pump depletion''. Based on the studies, the energy spread of the Laser-Plasma accelerators, caused by the longitudinal size of the beam, can be controlled through two procedures. The first procedure was based on Laser-Plasma parameters, including bunch length, beam loading (proportional to the plasma density), and the injection phase. The second procedure was based on Laser-Plasma environment density. It was found that energy spread can be minimized or even eliminated by selecting optimal values of both determinative parameters in a low-density cold plasma channel. Dephasing is another energy-gain factor where the electron beam reaches the decelerating region. Postponing the dephasing length will lead to energy-gain in the accelerator. The cold plasma can counteract the negative and unfavorable effect of rapid dephasing based on proposed simulations, and consequently, will increase the dephasing length. The pump depletion is another limiting factor, which is indeed the reduction in the transmitted pump power in a laser. The use of cold plasma as a low density plasma increases the depletion length which can enhance the accelerated energy. Dominating on Laser-Plasma accelerators, as explained, can maximize the energy-gain in the tumor. Hence, Hadrons transfer much more energy through the body to the target, leading to sufficient dose delivery and completing the elimination of cancerous tissue.
The advancement of accelerators over late years drives to a quickly expanding number of working frameworks which may result in the overload of the quantity of ion facility establishments in recent years. However, there are three conceivable outcomes for continuous need for laser-based treatment facilities. In order to start, running and future clinical preliminaries contrasting the clinical advantage of ion versus photon beams treatment uncover a startling higher preferred standpoint of the ion treatment. Second, the decrease in expenses by laser-based treatment feasibilities contrasted with traditional ion treatment is strong to the point that new establishments specifically will utilize it in the developing countries. Third, heavier ions result in a clinical advantage over protons for a bigger number of patients, persuading the establishment of financially affordable compact laser-based particle treatment feasibilities. Forthcoming, authors have decided to present innovative methods in Hadron therapy for energy enhancement due to precise and monotone accelerating toward a better cancer treatment with minor damages to the healthy tissues and solving the existent challenges.
